Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026
← Back to Research Index
Compare Evaluate Matrix Half-Life
Dossier · № 34 of 110 Updated Nov 17, 2026

AICAR

Acadesine

CLINICAL TRIALS (BANNED IN SPORT) · AMPK ACTIVATOR NUCLEOSIDE (NON-PEPTIDE)

▓ 198 indexed citations across PubMed (157), ClinicalTrials.gov (2), EuropePMC (39).

Citation breakdown by evidence tier

← weaker evidence  ·  stronger evidence →

198 citations across 8 tiers

Tap any tier to jump to that section of the bibliography.

Mechanism of action

AMP mimetic; activates AMPK; promotes fatty acid oxidation

Researched effects

AMPK activation; fat oxidation; endurance; exercise mimetic

Live evidence

Live signals refreshed daily. Current as of November 19, 2026.

Dosing reported in literature

500 mg IV in trials; 50-100 mg daily anecdotal

Known concerns

WADA-banned; hyperuricemia; potential cardiac effects

Top-ranked picks

10 pre-curated authoritative sources, ranked by journal tier and study weight.

  1. Effects of acadesine on myocardial infarction, stroke, and death following surgery. A meta-analysis of the 5 international randomized trials. The Multicenter Study of Perioperative Ischemia (McSPI) Research Group.

    JAMA · 1997 — META-ANALYSES · AUTHORITY 110.0

  2. Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial.

    JAMA · 2012 — RANDOMISED CONTROLLED TRIALS · AUTHORITY 91.2

  3. AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review.

    Cells · 2021 — SYSTEMATIC REVIEWS · AUTHORITY 84.1

  4. Post-reperfusion myocardial infarction: long-term survival improvement using adenosine regulation with acadesine.

    Journal of the American College of Cardiology · 2006 — RANDOMISED CONTROLLED TRIALS · AUTHORITY 82.6

  5. 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside acutely stimulates skeletal muscle 2-deoxyglucose uptake in healthy men.

    Diabetes · 2007 — CLINICAL TRIALS · AUTHORITY 77.7

  6. Effects of acadesine on the incidence of myocardial infarction and adverse cardiac outcomes after coronary artery bypass graft surgery. Multicenter Study of Perioperative Ischemia (McSPI) Research Group.

    Anesthesiology · 1995 — RANDOMISED CONTROLLED TRIALS · AUTHORITY 72.0

  7. Acadesine inhibits neutrophil CD11b up-regulation in vitro and during in vivo cardiopulmonary bypass.

    The Journal of thoracic and cardiovascular surgery · 1995 — RANDOMISED CONTROLLED TRIALS · AUTHORITY 72.0

  8. Acadesine: a new drug that may improve myocardial protection in coronary artery bypass grafting. Results of the first international multicenter study. Multinational Acadesine Study Group.

    The Journal of thoracic and cardiovascular surgery · 1995 — RANDOMISED CONTROLLED TRIALS · AUTHORITY 72.0

  9. Effect of acadesine, a new metabolic agent, on exercise-induced myocardial ischemia in chronic stable angina.

    Cardiovascular drugs and therapy · 1994 — RANDOMISED CONTROLLED TRIALS · AUTHORITY 72.0

  10. An initial multicenter, randomized controlled trial on the safety and efficacy of acadesine in patients undergoing coronary artery bypass graft surgery. SPI Research Group.

    Anesthesia and analgesia · 1994 — RANDOMISED CONTROLLED TRIALS · AUTHORITY 72.0

Full citation library

Year distribution

Meta-Analyses

1
  1. 1.

    Mangano DT · JAMA · 1997 · PMID 9002496

    To determine the effects of a purine nucleoside, acadesine, on the incidence of fatal and nonfatal cardiovascular and cerebrovascular complications following coronary artery bypass graft (CABG) surgery. Individual patient data from 5 randomized, placebo-controlled, double-blind clinical trials, including 81 international medical centers of the United States, Canada, and Europe. All patients from all clinical trials were included: a total of 4043 patients undergoing CABG surgery, evaluable for ef…

Systematic Reviews

1
  1. 2.

    Višnjić D, Lalić H, Dembitz V, Tomić B, et al. · Cells · 2021 · PMID 34064363

    5-Aminoimidazole-4-carboxamide ribonucleoside (AICAr) has been one of the most commonly used pharmacological modulators of AMPK activity. The majority of early studies on the role of AMPK, both in the physiological regulation of metabolism and in cancer pathogenesis, were based solely on the use of AICAr as an AMPK-activator. Even with more complex models of AMPK downregulation and knockout being introduced, AICAr remained a regular starting point for many studies focusing on AMPK biology. Howev…

Randomised Controlled Trials

7
  1. 3.

    Anesthesiology · 1995 · PMID 7574044

    Acadesine (AICA riboside) (5-amino-1-[beta-D-ribofuranosyl]imidazole-4-carboxamide) is a purine nucleoside analog belonging to a new class of agents generally termed adenosine regulating agents (ARAs) that increase the availability of adenosine locally in ischemic tissues. The effects of acadesine on the incidence of fatal and nonfatal myocardial infarction (MI) an on the incidence of all adverse cardiovascular outcomes (cardiac death, MI, congestive heart failure, life-threatening dysrhythmia,…

  2. 4.

    Mangano DT, Miao Y, Tudor IC, Dietzel C, et al. · Journal of the American College of Cardiology · 2006 · PMID 16814669

    The purpose of this study was to assess the safety and efficacy of the adenosine regulating agent (ARA) acadesine for reducing long-term mortality among patients with post-reperfusion myocardial infarction (MI). No prospectively applied therapy exists that improves long-term survival after MI associated with coronary artery bypass graft (CABG) surgery-a robust model of ischemia/reperfusion injury. Pretreatment with the purine nucleoside autocoid adenosine mitigates the extent of post-ischemic re…

  3. 5.

    Mathew JP, Rinder CS, Tracey JB, Auszura LA, et al. · The Journal of thoracic and cardiovascular surgery · 1995 · PMID 7877305

    Granulocyte adhesion to ischemic tissue, mediated in large part by beta 2 integrin receptors, is important in the pathophysiology of reperfusion injury. Acadesine, a drug that modulates adenosine levels in ischemic tissue, has been shown to reduce reperfusion injury in animal models of ischemia. The purpose of this study was to measure changes in granulocyte CD11b/CD18 in an in vitro assay and in an in vivo trial of acadesine administered during cardiopulmonary bypass to determine whether this a…

  4. 6.

    Menasché P, Jamieson WR, Flameng W, Davies MK · The Journal of thoracic and cardiovascular surgery · 1995 · PMID 7475138

    The effect of acadesine, an adenosine-regulating agent, on the incidence of myocardial infarction, all adverse cardiovascular outcomes (myocardial infarction, cardiac death, left ventricular dysfunction, life-threatening arrhythmia, or cerebrovascular accident) and mortality was assessed in 821 patients undergoing coronary artery bypass grafting. Patients were prospectively stratified to a high-risk group (age > 70 years, unstable angina, previous coronary bypass, unsuccessful angioplasty, or ej…

  5. 7.

    Holdright DR, Sparrow JL, Wright CL, Steiner J, et al. · Cardiovascular drugs and therapy · 1994 · PMID 7918131

    Acadesine, the first of a class of adenosine-regulating agents, has been shown to possess antiischemic properties in animal models. The aim of the study was to assess the effect of acadesine on exercise-induced myocardial ischemia in patients with chronic stable angina pectoris. Twelve patients with stable angina entered a five-way, randomized double-blind study comparing the effects of four doses of acadesine with placebo on time to 1 mm ST-segment depression and other parameters of exercise to…

  6. 8.

    Leung JM, Stanley T, Mathew J, Curling P, et al. · Anesthesia and analgesia · 1994 · PMID 7818622

    Acadesine (5-amino-4-imidazole carboxamide riboside) is a purine nucleoside analog that has been shown in animals to reduce myocardial ischemic injury by selectively increasing the availability of adenosine in ischemic tissues. Because patients undergoing coronary artery bypass graft (CABG) surgery are especially vulnerable to developing myocardial ischemia, we investigated whether perioperative use of this adenosine-regulating drug with potential anti-ischemic properties could modify the incide…

  7. 9.

    Newman MF, Ferguson TB, White JA, Ambrosio G, et al. · JAMA · 2012 · PMID 22782417

    Ischemia/reperfusion injury remains an important cause of morbidity and mortality after coronary artery bypass graft (CABG) surgery. In a meta-analysis of randomized controlled trials, perioperative and postoperative infusion of acadesine, a first-in-class adenosine-regulating agent, was associated with a reduction in early cardiac death, myocardial infarction, and combined adverse cardiac outcomes in participants undergoing on-pump CABG surgery. To assess the efficacy and safety of acadesine ad…

Clinical Trials

2
  1. 10.

    Van Den Neste E, Cazin B, Janssens A, González-Barca E, et al. · Cancer chemotherapy and pharmacology · 2013 · PMID 23228986

    Acadesine has shown in vitro to selectively induce apoptosis in B cells from chronic lymphocytic leukemia (CLL) patients. We conducted a phase I/II open-label clinical study, to determine the safety and tolerability of acadesine given intravenously as a 4-h infusion to CLL patients. Patient population included CLL patients with relapsed/refractory disease who had received one or more prior lines of treatment including either a fludarabine or an alkylator-based regimen. Twenty-four patients were…

  2. 11.

    Cuthbertson DJ, Babraj JA, Mustard KJ, Towler MC, et al. · Diabetes · 2007 · PMID 17513706

    Activation of AMP-activated protein kinase (AMPK) in rodent muscle by exercise, metformin, 5-aminoimidazole-4-carboxamide 1-beta-d-ribofuranoside (AICAR), and adiponectin increases glucose uptake. The aim of this study was to determine whether AICAR stimulates muscle glucose uptake in humans. We studied 29 healthy men (aged 26 +/- 8 years, BMI 25 +/- 4 kg/m(2) [mean +/- SD]). Rates of muscle 2-deoxyglucose (2DG) uptake were determined by measuring accumulation of total muscle 2DG (2DG and 2DG-6-…

Trial Registrations (ClinicalTrials.gov)

2
  1. 12.

    NCT00004314 · Phase 2 · Completed · 1996

    Conditions: Lesch-Nyhan Syndrome

  2. 13.

    NCT00168519 · NA · Completed · 2002

    Conditions: Diabetes Mellitus, Type 2

Reviews

10
  1. 14.

    Melton SM, Moomey CB, Ragsdale DN, Trenthem LL, et al. · Critical care medicine · 1999 · PMID 10199538

    To determine properties of acadesine, the prototype adenosine regulating agent, in an experimental model in which abdominal sepsis is superimposed onto hemorrhagic shock. Randomized, blinded animal study. University-based animal research facility. Twenty-eight anesthetized mongrel pigs (35.5 +/- 1.1 kg). The cecum was ligated and punctured to produce abdominal sepsis. To produce hemorrhagic shock, 45% to 47% of the estimated blood volume was withdrawn. After 1 hr, shed blood plus supplemental cr…

  2. 15.

    Gruber HE · Advances in experimental medicine and biology · 1994 · PMID 7660942

  3. 16.

    Drew BG, Kingwell BA · Expert opinion on pharmacotherapy · 2008 · PMID 18671468

    Acadesine is an adenosine-regulating agent that increases bioavailability of adenosine and has important metabolic effects, partly through activation of the key metabolic regulatory enzyme, AMP-activated protein kinase. This review aimed to summarise and critique available data on the mechanism of action and clinical utility of acadesine, with a focus on treatment of ischaemic reperfusion injury, B-cell chronic lymphocytic leukaemia and diabetes mellitus. The literature was acquired through nume…

  4. 17.

    Mullane K · Cardiovascular research · 1993 · PMID 8458030

    Acadesine is the prototype of a new class of therapeutic compounds termed adenosine regulating agents. Acadesine is pharmacologically silent in normal circumstances, but its activity becomes operative during situations of net ATP catabolism, when it increases local adenosine levels. Thus acadesine is able to harness the beneficial effects of this protective autacoid without the limiting side effects associated with using adenosine itself or an adenosine mimetic or transport inhibitor. The demons…

  5. 18.

    Baggott JE, Tamura T · Advances in nutrition (Bethesda, Md.) · 2015 · PMID 26374178

    Purine nucleotide biosynthesis de novo (PNB) requires 2 folate-dependent transformylases-5'-phosphoribosyl-glycinamide (GAR) and 5'-phosphoribosyl-5-aminoimidazole-4-carboxamide (AICAR) transformylases-to introduce carbon 8 (C8) and carbon 2 (C2) into the purine ring. Both transformylases utilize 10-formyltetrahydrofolate (10-formyl-H4folate), where the formyl-carbon sources include ring-2-C of histidine, 3-C of serine, 2-C of glycine, and formate. Our findings in human studies indicate that gly…

  6. 19.

    Baggott JE, Tamura T · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2001 · PMID 11686579

    The metabolism of 10-formyldihydrofolate is reviewed in this article. It had been the dogma that only tetrahydrofolates participate in enzyme-catalyzed one-carbon transfer reactions, until we showed in 1986 that 10-formyldihydrofolate serves as a substrate for aminoimidazolecarboxamide ribotide (AICAR) transformylase. Our data from studies in humans, cultured cells and bacteria as well as in vitro experiments indicate that the oxidation of 10-formyltetrahydrofolate to 10-formyldihydrofolate take…

  7. 20.

    Visnjic D, Dembitz V, Lalic H · Current medicinal chemistry · 2019 · PMID 29345570

    Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid represents the most successful pharmacological therapy of acute myeloid leukemia (AML). Numerous studies demonstrate that drugs that inhibit mechanistic target of rapamycin (mTOR) and activate AMP-kinase (AMPK) have beneficial effects in promoting differentiation and blocking proliferation of AML. Most of these drugs are already in use for other purposes; rapalogs as immunosuppressants, biguanides as oral antidi…

  8. 21.

    Van Den Neste E, Van den Berghe G, Bontemps F · Expert opinion on investigational drugs · 2010 · PMID 20367195

    Despite considerable advances, B-cell chronic lymphocytic leukemia (CLL) is incurable with standard approaches. Thus, there remains a need for new therapies, particularly for patients who develop chemoresistance to DNA-targeting treatments. AICA-riboside (acadesine) is a nucleoside with a wide range of metabolic effects, including release of adenosine and activation of AMP-activated protein kinase (AMPK), which was initially developed as a cardioprotective agent. More recently, it has been shown…

  9. 22.

    Baggott JE, Tamura T · Experimental biology and medicine (Maywood, N.J.) · 2010 · PMID 20404044

    We postulate that 10-formyl-7,8-dihydrofolate (10-HCO-H(2)folate), not 10-formyl-5,6,7,8-tetrahydrofolate (10-HCO-H(4)folate), is the predominant in vivo substrate for mammalian aminoimidazolecarboxamide ribotide (AICAR) transformylase, an enzyme in purine nucleotide biosynthesis de novo, which introduces carbon 2 (C(2)) into the purine ring. 10-HCO-H(2)folate exists in vivo as labeled 10-formyl-folic acid (10-HCO-folic acid: an oxidation product of 10-HCO-H(4)folate and 10-HCO-H(2)folate) and i…

  10. 23.

    Engler RL · Journal of cardiac surgery · 1994 · PMID 8069041

    Although the effects of adenosine on the heart, including the clinical suppression of cardiac arrhythmias, have been recognized for more than half a century, it is only in the last decade that the therapeutic potential of adenosine has been recognized. Research related to the clinical application of adenosine has concentrated on two areas. The first came directly from early observations about the use of adenosine in treating cardiac arrhythmias, in particular supraventricular tachycardias. The s…

Research Articles

171
  1. 24.

    Choksey A, Carter RD, Thackray BD, Ball V, et al. · Journal of molecular and cellular cardiology · 2024 · PMID 38643934

    Doxorubicin (DOX) is a widely used chemotherapeutic agent that can cause serious cardiotoxic side effects, leading to heart failure (HF). Impaired mitochondrial function is thought to be key factor driving progression into HF. We have previously shown in a rat model of DOX-HF that heart failure with reduced ejection fraction correlates with mitochondrial loss and dysfunction. Adenosine monophosphate-dependent kinase (AMPK) is a cellular energy sensor, regulating mitochondrial biogenesis and ener…

  2. 25.

    Fu Y, Hou J, Yang Q, Lin Y, et al. · Journal of nanobiotechnology · 2025 · PMID 40616103

    Osteoarthritis (OA), the most prevalent joint disorder, is characterized by a complex etiology and a lack of safe and effective therapeutic interventions. Emerging evidence suggests that immune cell dysregulation plays a pivotal role in the pathogenesis of OA. Recent advancements in high-throughput sequencing technologies, along with the integration of machine learning into medical research, have provided novel insights into the molecular mechanisms underlying various diseases. However, the spec…

  3. 26.

    Efstathiou NE, Moustafa GA, Maidana DE, Konstantinou EK, et al. · PloS one · 2020 · PMID 33362238

    Age-related macular degeneration (AMD) is the most prevalent form of irreversible blindness in the developed world. Aging, inflammation and complement dysregulation affecting the retinal pigment epithelium (RPE), are considered significant contributors in its pathogenesis and several evidences have linked tumor necrosis factor alpha (TNF-α) and complement component 3 (C3) with AMD. Acadesine, an analog of AMP and an AMP-activated protein kinase (AMPK) activator, has been shown to have cytoprotec…

  4. 27.

    Chandrasekaran K, Choi J, Salimian M, Hedayat AF, et al. · International journal of molecular sciences · 2024 · PMID 39795939

    Diabetic peripheral neuropathy (DPN) is a common complication of diabetes in both Type 1 (T1D) and Type 2 (T2D). While there are no specific medications to prevent or treat DPN, certain strategies can help halt its progression. In T1D, maintaining tight glycemic control through insulin therapy can effectively prevent or delay the onset of DPN. However, in T2D, overall glucose control may only have a moderate impact on DPN, although exercise is clearly beneficial. Unfortunately, optimal exercise…

  5. 28.

    Galiñanes M, Bullough D, Mullane KM, Hearse DJ · Circulation · 1992 · PMID 1638724

    We have shown that acadesine (AICAr: 5-amino-4-imidazole carboxamide riboside) improves the early recovery of function of the ischemic and reperfused rat heart. In the present studies we used the transplanted rat heart, with reperfusion for up to 24 hours, to assess whether the beneficial effect of acadesine is a transient or a sustained phenomenon (i.e., to determine whether the drug improves the extent of recovery or only the rate). Hearts (n = 8 per group) were excised and immediately arreste…

  6. 29.

    Ying H, Xingyi L, Jun L, Peiting L, et al. · Tissue & cell · 2025 · PMID 40203680

    Rheumatoid arthritis (RA) leads to joint deformities and diminishes quality of life if not managed promptly. Investigating Iguratimod effects on osteoclast differentiation in RA patients could provide insights into disease management. Peripheral blood mononuclear cells (PBMCs) were extracted from blood samples taken from RA patients. TRAP staining confirmed the ability of these cells to differentiate into osteoclasts. Those cells were treated with Iguratimod, AMPK agonist (AICAR), and HIF-1α int…

  7. 30.

    Campàs C, Lopez JM, Santidrián AF, Barragán M, et al. · Blood · 2003 · PMID 12522004

    Acadesine, 5-aminoimidazole-4-carboxamide (AICA) riboside, induced apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells in all samples tested (n = 70). The half-maximal effective concentration (EC(50)) for B-CLL cells was 380 +/- 60 microM (n = 5). The caspase inhibitor Z-VAD.fmk completely blocked acadesine-induced apoptosis, which involved the activation of caspase-3, -8, and -9 and cytochrome c release. Incubation of B-CLL cells with acadesine induced the phosphorylation of adenosin…

  8. 31.

    Robert G, Ben Sahra I, Puissant A, Colosetti P, et al. · PloS one · 2009 · PMID 19924252

    CML is an hematopoietic stem cell disease characterized by the t(9;22) (q34;q11) translocation encoding the oncoprotein p210BCR-ABL. The effect of acadesine (AICAR, 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside) a compound with known antileukemic effect on B cell chronic lymphoblastic leukemia (B-CLL) was investigated in different CML cell lines. Acadesine triggered loss of cell metabolism in K562, LAMA-84 and JURL-MK1 and was also effective in killing imatinib-resistant K562 cells and…

  9. 32.

    Zhang W, Wang J, Wang H, Tang R, et al. · Arteriosclerosis, thrombosis, and vascular biology · 2010 · PMID 20185792

    Acadesine, an adenosine-regulating agent and activator of AMP-activated protein kinase, has been shown to possess antiinflammatory activity. This study investigated whether and how acadesine inhibits tissue factor (TF) expression and thrombus formation. Human umbilical vein endothelial cells and human peripheral blood monocytes were stimulated with lipopolysaccharide to induce TF expression. Pretreatment with acadesine dramatically suppressed the clotting activity and expression of TF (protein a…

  10. 33.

    Fassett EK, Mayer B, Fassett JT · Cellular and molecular life sciences : CMLS · 2025 · PMID 41231272

    Doxorubicin is an effective cancer chemotherapeutic, but its use is complicated by cardiotoxic side-effects. 5-amino-4-imidazolecarboxamide ribonucleoside (AICAr) is a widely used pharmacological activator of adenosine monophosphate-activated kinase (AMPK), but also exerts AMPK-independent actions that may have unrealized therapeutic potential. Here, we identified a novel mechanism by which pretreatment with AICAr protects neonatal rat cardiomyocytes against doxorubicin toxicity. Despite increas…

  11. 34.

    Galiñanes M, Mullane KM, Bullough D, Hearse DJ · Circulation · 1992 · PMID 1638725

    Although there are many factors that might contribute to tissue injury during ischemia and reperfusion, the loss of adenine nucleotides has long been considered to be of importance. This has led to the study of interventions designed to limit the loss of nucleotides or to enhance the rate of nucleotide resynthesis during reperfusion. Alternatively, the breakdown of adenosine triphosphate to adenosine might represent a protective response of the ischemic heart because adenosine is considered an a…

  12. 35.

    Dietrich WD, Miller LP, Prado R, Dewanjee S, et al. · Stroke · 1995 · PMID 7839379

    The adenosine-regulating agent acadesine has been shown to reduce the incidence of myocardial infarction and stroke after cardiopulmonary bypass surgery. The present study examined the effect of acadesine on the accumulation of indium-labeled platelet emboli and infarct size after photothrombosis of the common carotid artery. Rats were anesthetized with halothane and preloaded with 111In-tropolone-labeled platelets (50 to 80 microCi) 30 minutes before nonocclusive common carotid artery thrombosi…

  13. 36.

    Lasley RD, Randhawa MP, Hegge JO, Mentzer RM · Canadian journal of physiology and pharmacology · 1999 · PMID 10535674

    5-Amino-4-imidazolecarboxamide riboside (AICAr) or acadesine has been proposed to exert cardioprotection by enhancing adenosine production in ischemic myocardium. However, there are conflicting reports on acadesine's effects in ischemic myocardium and few studies in which myocardial adenosine levels have been measured. The purpose of this study was to determine whether acadesine increases interstitial fluid adenosine levels and attenuates myocardial stunning or potentiates the effects of adenosi…

  14. 37.

    Bolling SF, Groh MA, Mattson AM, Grinage RA, et al. · The Annals of thoracic surgery · 1992 · PMID 1610261

    To test if acadesine (5-aminoimidazole-4-carboxamide riboside), a purine precursor, has cardioprotective effects, 16 dogs were placed on total cardiopulmonary bypass and subjected to global myocardial ischemia. Hemodynamic recovery was compared between a control (n = 8) group receiving standard cardioplegia and an acadesine (n = 8) group pretreated with intravenous acadesine (2.5 mg.kg-1.min-1 for 5 minutes, then 0.5 mg.kg-1.min-1) before ischemia, during ischemia, and until 10 minutes after rem…

  15. 38.

    Sobolevsky T, Piper T, Ahrens B, Thevis M · Drug testing and analysis · 2022 · PMID 36342242

    AICAr (5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside, commonly referred to as AICAR) is an adenosine monophosphate-activated protein kinase agonist previously investigated for its therapeutic potential which has been shown to improve exercise performance in laboratory animals. For this reason, the World Anti-Doping Agency prohibits the use of AICAr in sports. AICAr can easily be detected by means of liquid chromatography-mass spectrometry, but being an endogenous metabolite, it cannot be d…

  16. 39.

    Han WM, Hong YX, Xiao GS, Wang RY, et al. · Cell death discovery · 2024 · PMID 38233385

    N-methyl-D-aspartate receptors (NMDARs) are ligand-gated, voltage-dependent channels of the ionotropic glutamate receptor family. The present study explored whether NMDAR activation induced ferroptosis in vascular endothelial cells and its complicated mechanisms in vivo and in vitro. Various detection approaches were used to determine the ferroptosis-related cellular iron content, lipid reactive oxygen species (LOS), siRNA molecules, RNA-sequence, MDA, GSH, and western blotting. The AMPK activat…

  17. 40.

    Dixon R, Fujitaki J, Sandoval T, Kisicki J · Journal of clinical pharmacology · 1993 · PMID 8227467

    Acadesine (AICA-riboside) is a purine nucleoside analog with anti-ischemic properties that is currently being studied (Phase 3) for the prevention of adverse cardiovascular outcomes in patients undergoing coronary artery bypass graft (CABG) surgery. The safety, tolerance, and pharmacokinetics of the drug have previously been reported in this journal (J Clin Pharmacol 1991; 31:342-347). Recently, the authors studied the disposition and metabolism of acadesine in healthy males (n = 4) after a 15-m…

  18. 41.

    Xuan L, Yang S, Ren L, Liu H, et al. · Journal of natural medicines · 2024 · PMID 38175326

    Akebia saponin D (ASD) is a bioactive triterpenoid saponin extracted from Dipsacus asper Wall. ex DC.. This study aimed to investigate the effects of ASD on allergic airway inflammation. Human lung epithelial BEAS-2B cells and bone marrow-derived mast cells (BMMCs) were pretreated with ASD (50, 100 and 200 μΜ) and AMPK activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) (1 mM), and then stimulated with lipopolysaccharide (LPS) or IL-33. Pretreatment with ASD and AICAR significa…

  19. 42.

    Aftab F, Rodriguez-Fuguet A, Silva L, Kobayashi IS, et al. · British journal of cancer · 2023 · PMID 36810913

    Lung cancer cells overexpress mucin 1 (MUC1) and active subunit MUC1-CT. Although a peptide blocks MUC1 signalling, metabolites targeting MUC1 are not well studied. AICAR is a purine biosynthesis intermediate. Cell viability and apoptosis were measured in AICAR-treated EGFR-mutant and wild-type lung cells. AICAR-binding proteins were evaluated by in silico and thermal stability assays. Protein-protein interactions were visualised by dual-immunofluorescence staining and proximity ligation assay.…

  20. 43.

    Fabian TC, Fabian MJ, Yockey JM, Proctor KG · Surgery · 1996 · PMID 8619186

    We have reported that the purine precursor acadesine (AICAR) improved the microcirculation, repleted adenosine triphosphate, and attenuated local and lung neutrophil infiltration after intestinal reperfusion and that it quickly improved systemic hemodynamics after resuscitation from hemorrhagic shock. This study evaluated the therapeutic potential of AICAR after fluid resuscitated trauma. Anesthetized (fentanyl) mongrel pigs were subjected to tissue injury plus hemorrhage and randomized to recei…

  21. 44.

    Tsuchida A, Yang XM, Burckhartt B, Mullane KM, et al. · Cardiovascular research · 1994 · PMID 8174159

    The aim was to test whether acadesine (5-amino-4-imidazolecarboxamide riboside, AICAR), an adenosine regulating agent which increases tissue adenosine during ischaemia, could prolong the window of protection from ischaemic preconditioning. A branch of the left coronary artery of a rabbit heart was occluded for 30 min and reperfused for 180 min to induce infarction. Infarct size was determined with triphenyl tetrazolium staining. Prior to the 30 min ischaemia, rabbits were subjected to one of the…

  22. 45.

    Tsai WL, Hsu CN, Tain YL · Nutrients · 2020 · PMID 32053935

    High consumption of saturated fats links to the development of hypertension. AMP-activated protein kinase (AMPK), a nutrient-sensing signal, is involved in the pathogenesis of hypertension. We examined whether early intervention with a direct AMPK activator 5-aminoimidazole-4-carboxamide riboside (AICAR) during pregnancy or lactation can protect adult male offspring against hypertension programmed by high saturated fat consumption via regulation of nutrient sensing signals, nitric oxide (NO) pat…

  23. 46.

    Burckhartt B, Yang XM, Tsuchida A, Mullane KM, et al. · Cardiovascular research · 1995 · PMID 7606753

    Ischaemic preconditioning protects myocardium from infarction if the reperfusion interval between the brief and prolonged ischaemic intervals is less than 1 h. In anaesthetised rabbits acadesine (5-amino-4-imidazolecarboxamide riboside, AICAR), an adenosine enhancer which increases tissue adenosine during ischaemia, prolongs the window of protection to 2 h. The aim of this study was to try to determine the maximum extension of this window of protection, using chronically instrumented, unsedated…

  24. 47.

    Bullough DA, Zhang C, Montag A, Mullane KM, et al. · The Journal of clinical investigation · 1994 · PMID 7929829

    Inhibition of platelet aggregation by acadesine was evaluated both in vitro and ex vivo in human whole blood using impedance aggregometry, as well as in vivo in a canine model of platelet-dependent cyclic coronary flow reductions. In vitro, incubation of acadesine in whole blood inhibited ADP-induced platelet aggregation by 50% at 240 +/- 60 microM. Inhibition of platelet aggregation was time dependent and was prevented by the adenosine kinase inhibitor, 5'-deoxy 5-iodotubercidin, which blocked…

  25. 48.

    Montraveta A, Xargay-Torrent S, López-Guerra M, Rosich L, et al. · Oncotarget · 2014 · PMID 24519895

    Mantle cell lymphoma (MCL) is considered one of the most challenging lymphoma, with limited responses to current therapies. Acadesine, a nucleoside analogue has shown antitumoral effects in different preclinical cancer models as well as in a recent phase I/II clinical trial conducted in patients with chronic lymphocytic leukemia. Here we observed that acadesine exerted a selective antitumoral activity in the majority of MCL cell lines and primary MCL samples, independently of adverse cytogenetic…

  26. 49.

    Torres RJ, Puig JG · Nucleosides, nucleotides & nucleic acids · 2018 · PMID 29634397

    The neurological manifestations of Lesch-Nyhan disease (LND) have been attributed to the effect of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency on nervous system development. An increase has been reported in the levels of 5-aminoimidazole-4-carboxamide-1-β-D-ribotide (AICAR) and its triphosphate form ZTP in the red blood cells of patients with LND. AICAR accumulation in the brain has been hypothesized as the cause of some of the neurological symptoms of patients with LND. In…

  27. 50.

    Gan L, Li W, Zhang Y, Zeng J, et al. · Cellular and molecular life sciences : CMLS · 2026 · PMID 41644729

    This study aims to elucidate the synergistic protective mechanism of the AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) in ischemia-reperfusion injury -associated acute kidney injury (IRI-AKI). By establishing a hypoxia/reoxygenation (H/R) injury model using human proximal tubule cells (HK-2) and IRI-AKI rat model, and employing molecular techniques including qRT-PCR, western blotting, serum biochemical assays, renal tissue hematoxylin and eosin staining, immunofluorescence,…

  28. 51.

    Montraveta A, Xargay-Torrent S, Rosich L, López-Guerra M, et al. · Oncotarget · 2015 · PMID 26110568

    Acadesine is a nucleoside analogue with known activity against B-cell malignancies. Herein, we showed that in mantle cell lymphoma (MCL) cells acadesine induced caspase-dependent apoptosis through turning on the mitochondrial apoptotic machinery. At the molecular level, the compound triggered the activation of the AMPK pathway, consequently modulating known downstream targets, such as mTOR and the cell motility-related vasodilator-stimulated phosphoprotein (VASP). VASP phosphorylation by acadesi…

  29. 52.

    Zhao ZQ, Williams MW, Sato H, Hudspeth DA, et al. · Cardiovascular research · 1995 · PMID 7796443

    The aim was to test the hypotheses that acadesine (1) augments endogenous interstitial fluid (ISF) adenosine during ischaemia, and (2) reduces infarct size by adenosine receptor mediated mechanisms. To test these hypotheses, the left coronary artery of anaesthetised rabbits (n = 33) was occluded for 30 min and reperfused for 120 min. Acadesine (1 mg.kg-1.min-1 for 5 min, then 0.2 mg.kg-1.min-1) was infused intravenously beginning 30 min before coronary occlusion and ending 30 min after reperfusi…

  30. 53.

    Zhou D, Ai Q, Lin L, Gong X, et al. · Innate immunity · 2015 · PMID 25979627

    The AMP-activated protein kinase (AMPK)-mediated energy-sensing signals play important roles in reprogramming the expression of inflammatory genes. In the present study, the potential effects of the AMPK activator 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) were investigated in a mouse model with LPS/D-Gal-induced acute hepatitis. Our experimental data indicated that treatment with AICAR suppressed the elevation of plasma aminotransferases and alleviated the histopathological abn…

  31. 54.

    Drugs in R&D · 2008 · PMID 18457469

    Acadesine is an adenosine receptor agonist (ARA) in development for the treatment of ischaemia-reperfusion injury and chronic lymphocytic leukaemia. Schering-Plough is developing the compound as a cardioprotective agent in ischaemia-reperfusion injury. Avancell and Protherics are co-developing acadesine for the treatment of B-cell chronic lymphocytic leukaemia (B-CLL). Clinical development is underway for both indications. In January 2005, PeriCor Therapeutics obtained a sublicense for the world…

  32. 55.

    Young MA, Henry C, Wong S, Bullough D, et al. · Thrombosis and haemostasis · 1995 · PMID 8607121

    Acadesine is a ribose-substituted imidazole with antithrombotic properties mediated by adenosine. In view of the beneficial effects of antiplatelet agents on thrombolysis and post-thrombolytic reocclusion, we studied the effects of acadesine on t-PA induced coronary reperfusion and continued artery thrombosis. In 4 groups of dogs we examined the effects of saline and 3 doses of acadesine (0.5, 1.0, 2.0 mg/kg/min, i.v.) on time reperfusion, and incidence and time to reocclusion following infusion…

  33. 56.

    Khorraminejad-Shirazi M, Sani M, Talaei-Khozani T, Dorvash M, et al. · Stem cell research & therapy · 2020 · PMID 32014016

    Mesenchymal stromal cell (MSC) stemness capacity diminishes over prolonged in vitro culture, which negatively affects their application in regenerative medicine. To slow down the senescence of MSCs, here, we have evaluated the in vitro effects of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an AMPK activator, and nicotinamide (NAM), an activator of sirtuin1 (SIRT1). Human adipose-derived MSCs were cultured to passage (P) 5. Subsequently, the cells were grown in either normal medium alo…

  34. 57.

    Ishibashi Y, Quebbeman BB, Duncker DJ, Klassen C, et al. · Journal of cardiovascular pharmacology · 1998 · PMID 9781923

    Acadesine, an adenosine-regulating agent, has been shown to increase coronary flow and exert cardioprotective effects in acutely ischemic myocardium, but a beneficial effect on coronary collateral flow during exercise has not been demonstrated. We examined the effect of acadesine, 100 micromol/min, i.v., on myocardial blood flow during treadmill exercise in six normal dogs and seven dogs with moderately well-developed coronary collateral vessels. Collateral vessel growth was produced with 2-min…

  35. 58.

    Bullough DA, Potter S, Fox MH, Zhang C, et al. · The Journal of pharmacology and experimental therapeutics · 1993 · PMID 8394912

    Acadesine is a cardioprotective nucleoside that can attenuate postischemic contractile dysfunction in the isolated heart even if administered at reperfusion, thereby implying an effect on a reperfusion-induced component of injury. Consequently, the effects of acadesine on the maintenance of cardiac function were evaluated in isolated guinea pig hearts in which the perfusion buffer was subjected to electrolysis to produce a mixture of free radicals and oxidants that have been implicated in reperf…

  36. 59.

    Aikawa A, Kozako T, Kato N, Ohsugi T, et al. · European journal of pharmacology · 2023 · PMID 37956732

    Adult T-cell leukemia/lymphoma (ATL) is an aggressive T cell leukemia/lymphoma caused by human T-cell lymphotropic virus type I (HTLV-1). Acadesine or 5-aminoimidazole-4-carboxamide riboside (AICAR) is an AMP-activated protein kinase (AMPK) activator that was recently shown to have tumor suppressive effects on B cell chronic lymphocytic leukemia, but not ATL. This study evaluated the cytotoxic effects of AICAR on ATL-related cell lines and its anti-tumor activity. Here, we demonstrated that AICA…

  37. 60.

    Guo F, Liu SQ, Gao XH, Zhang LY · Biochemical and biophysical research communications · 2016 · PMID 27103440

    AICAR (5-Aminoimidazole-4-carboxamide riboside or acadesine) is an AMP-activated protein kinase (AMPK) agonist, which induces cytotoxic effect to several cancer cells. Its potential activity in prostate cancer cells and the underlying signaling mechanisms have not been extensively studied. Here, we showed that AICAR primarily induced programmed necrosis, but not apoptosis, in prostate cancer cells (LNCaP, PC-3 and PC-82 lines). AICAR's cytotoxicity to prostate cancer cells was largely attenuated…

  38. 61.

    Ragsdale DN, Proctor KG · Critical care medicine · 2000 · PMID 11153629

    To determine actions of the prototype adenosine-regulating agent, acadesine (5-amino-1-[beta-D-ribofuranosyl]imidazole-4-carboxamideriboside; AICAR), on intestinal barrier function after hemorrhagic shock and fluid resuscitation, three series of experiments were performed to measure functional (series 1: intestinal permeability and intramural blood flow), structural (series 2: histology), and biochemical (series 3: tissue concentrations of adenine nucleotides and metabolites) changes. Prospectiv…

  39. 62.

    Zhu X, Duan F, Zhang Y, Wang X, et al. · International immunopharmacology · 2022 · PMID 35987144

    Severe acute pancreatitis (SAP) is a condition characterized by highly fatal acute inflammation and is usually associated with multiple organ dysfunction syndrome. Acute lung injury (ALI) is the most common complications of SAP, which is the accelerator of other organ dysfunction caused by SAP and the primary cause of early death due to SAP. Acadesine, an adenosine analog and an AMPK activator, has been discovered to modulate glucose and lipid metabolism, and inhibit the production of pro-inflam…

  40. 63.

    Gruver EJ, Toupin D, Smith TW, Marsh JD · Journal of molecular and cellular cardiology · 1994 · PMID 7815461

    The ability of acadesine to modulate injury in a myocyte model of simulated ischemia was studied. When freshly isolated adult rat ventricular myocytes were subjected to 10 min of simulated ischemia and reperfusion, greater that 75% of myocytes developed hypercontracture and the amplitude of contraction of the remaining, potentially viable myocytes was markedly depressed. When cells were pretreated with 50 microM acadesine for 5 min and exposed to acadesine during simulated ischemia and during 2-…

  41. 64.

    Matot I, Jurim O · Anesthesia and analgesia · 2001 · PMID 11226083

    The purine precursor acadesine is highly effective in preventing ischemia-reperfusion (I-R) injury of the heart and intestine. The aim of this study was to test the effect of acadesine on I-R--induced lung injury. The lobar artery of the left lower lung lobe in intact-chest, spontaneously breathing cats was occluded for 2 h (Group 1, ischemia) and reperfused for 3 h (Group 2, I-R). Animals were subjected to one of the following three protocols: acadesine administered IV 15 min before ischemia (G…

  42. 65.

    Boß M, Newbatt Y, Gupta S, Collins I, et al. · Scientific reports · 2016 · PMID 27562249

    Obesity-associated insulin resistance is driven by inflammatory processes in response to metabolic overload. Obesity-associated inflammation can be recapitulated in cell culture by exposing macrophages to saturated fatty acids (SFA), and endoplasmic reticulum (ER) stress responses essentially contribute to pro-inflammatory signalling. AMP-activated protein kinase (AMPK) is a central metabolic regulator with established anti-inflammatory actions. Whether pharmacological AMPK activation suppresses…

  43. 66.

    Börgeson E, Wallenius V, Syed GH, Darshi M, et al. · Diabetologia · 2017 · PMID 28188334

    In this study, we aimed to evaluate the therapeutic potential of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an activator of AMP-activated protein kinase, for ameliorating high-fat diet (HFD)-induced pathophysiology in mice. We also aimed to determine whether the beneficial effects of AICAR were dependent on adiponectin. Furthermore, human adipose tissue was used to examine the effect of AICAR ex vivo. Six-week-old male C57BL/6J wild-type and Adipoq AICAR attenuated adipose inflammati…

  44. 67.

    Li F, Sun A, Cheng G, Liu D, et al. · Frontiers in physiology · 2020 · PMID 33424637

    AICAR (Acadesine/AICA riboside) as an activator of AMPK, can protect renal tubular cells from cisplatin induced apoptosis. But in our experiment, the dorsomorphin (compound C, an inhibitor of AMPK) also significantly reduced cisplatin induced renal tubular cells apoptosis. Accordingly, we tested whether compound C can protect cisplatin-induced nephrotoxicity and the specific mechanism. Here, we treated Boston University mouse proximal tubular cells (BUMPT-306) with cisplatin and/or different dos…

  45. 68.

    Yamagishi A, Yonemochi N, Kimura A, Takenoya F, et al. · British journal of pharmacology · 2024 · PMID 39295124

    Diabetic patients have an increased risk of psychiatric disorders. Because hyperglycaemia increases L-lactate in the brain and L-lactate inhibits AMP-activated protein kinase (AMPK), this study investigated the role of L-lactate and AMPK in strengthened fear memory, a model for human psychiatric disorders, in diabetic mice. The diabetic model was mice injected with streptozotocin. Fear memory was measured using the conditioned fear test with low (0.45 mA) or high (0.50 mA) foot shock to cause lo…

  46. 69.

    Angelini A, Ortiz-Urbina J, Trial J, Reddy AK, et al. · American journal of physiology. Heart and circulatory physiology · 2022 · PMID 35714177

    The incidence of diastolic dysfunction increases with age in both humans and mice. This is characterized by increased passive stiffness and slower relaxation of the left ventricle. The stiffness arises at least partially from progressively increased interstitial collagen deposition because of highly secretory fibroblasts. In the past, we demonstrated that AMPK activation via the drug 5-aminoimidazole-4-carboxamide riboside (AICAR) in middle-aged mice reduced adverse remodeling after myocardial i…

  47. 70.

    Bush ND, Townsend LK, Wright DC · The Journal of pharmacology and experimental therapeutics · 2018 · PMID 29581153

    Olanzapine (OLZ) is an antipsychotic drug used in the treatment of schizophrenia. Although effective in reducing psychoses, OLZ causes acute increases in blood glucose. The acute effects of OLZ on hyperglycemia are likely caused by reductions in insulin secretion, insulin resistance, and increased hepatic glucose production. 5AMP-activated protein kinase (AMPK) is an energy sensor activated during exercise that can increase insulin sensitivity and insulin-independent glucose uptake in muscle. 5-…

  48. 71.

    Chung EJ, Efstathiou NE, Konstantinou EK, Maidana DE, et al. · Scientific reports · 2017 · PMID 29247196

    Age related macular degeneration is the leading cause of blindness in the developed world. Although its precise cause remains elusive, dysfunction of the retinal pigment epithelium (RPE) and dysregulation of complement have been implicated in its pathogenesis. The goal of this study was to evaluate the role of an AMP-dependent kinase (AMPK) activator, 5-aminoimidazole-4-carboxamide riboside (AICAR), on tumor necrosis factor alpha (TNF-α) induction of complement factor B (CFB) in RPE cells. We fo…

  49. 72.

    Unkle DW · Critical care medicine · 1999 · PMID 10199518

  50. 73.

    Krishnan U A, Viswanathan P, Venkataraman AC · Tissue & cell · 2023 · PMID 36913846

    Dysregulation of 5'-adenosine monophosphate-activated protein kinase (AMPK) occurs in metabolic disorders including non-alcoholic fatty liver disease (NAFLD) which makes it a molecular target for treatment. An AMPK activator, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR) alleviates NAFLD in experimental rats, however the specific mechanism remains to be explored. We aimed to study the effect of AICAR on lipid levels, oxidant-antioxidant balance, AMPK and mTOR activation and FOXO3 g…

  51. 74.

    Vinten-Johansen J, Nakanishi K, Zhao ZQ, McGee DS, et al. · Circulation · 1993 · PMID 8222178

    Adenosine is a cardioprotective autacoid that exerts receptor-mediated protection from ischemia/reperfusion injury. In ischemically injured hearts, avoidance of ischemia/reperfusion injury with hypothermic chemical cardioplegia may be incomplete, and consequently, postischemic left ventricular (LV) function may be severely depressed and chamber stiffness increased. This study tested the hypothesis that the adenosine-regulating agent acadesine improves myocardial protection with hypothermic blood…

  52. 75.

    Schoenberg MH, Poch B, Moch D, Marzinzig M, et al. · The American journal of physiology · 1995 · PMID 7503274

    Hemorrhagic mucosal lesions are produced during intestinal ischemia and after reperfusion due at least in part to the accumulation and activation of polymorphonuclear leukocytes in the tissue. It has been shown in vitro that adenosine is instrumental in attenuating this pathophysiological process. Acadesine [5-amino-4-imidazolecarboxamide (AICA) riboside], a purine nucleoside analogue, increases the availability of adenosine in the tissue. The aim of the study was therefore to assess the influen…

  53. 76.

    Wall M, Shim JH, Benkovic SJ · Biochemistry · 2000 · PMID 10985775

    We have prepared 4-substituted analogues of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) to investigate the specificity and mechanism of AICAR transformylase (AICAR Tfase). Of the nine analogues of AICAR studied, only one analogue, 5-aminoimidazole-4-thiocarboxamide ribonucleotide, was a substrate, and it was converted to 6-mercaptopurine ribonucleotide. The other analogues either did not bind or were competitive inhibitors, the most potent being 5-amino-4-nitroimidazole ribonucleotide…

  54. 77.

    Wu Y, Duan X, Gao Z, Yang N, et al. · PloS one · 2022 · PMID 36048820

    Postoperative abdominal adhesion is one of most common complications after abdominal operations. 5-aminoimidazole-4-carboxyamide ribonucleoside (AICAR) is an adenosine 5'-monophosphate activated protein kinase (AMPK) pathway agonist that inhibits inflammation, reduces cell fibrosis and cellular reactive oxygen species (ROS) injury, promotes autophagy and mitochondrial function. This study aimed to explore the mechanism of AICAR in inhibiting adhesion formation. Forty rats were randomly divided i…

  55. 78.

    Lonare S, Rode S, Verma P, Verma S, et al. · Biochimica et biophysica acta. Proteins and proteomics · 2024 · PMID 38615986

    The bifunctional enzyme, 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase/inosine monophosphate (IMP) cyclohydrolase (ATIC) is involved in catalyzing penultimate and final steps of purine de novo biosynthetic pathway crucial for the survival of organisms. The present study reports the characterization of ATIC from Candidatus Liberibacer asiaticus (CLasATIC) along with the identification of potential inhibitor molecules and evaluation of cell proliferative activity. CLasATIC s…

  56. 79.

    Nawarskas JJ · Heart disease (Hagerstown, Md.) · 1999 · PMID 11720632

    Acadesine is the prototype of a new class of drugs referred to as adenosine-regulating agents. These drugs act by increasing adenosine generation from adenosine monophosphate during conditions of myocardial ischemia. Adenosine itself has many beneficial cardioprotective properties that may therefore be harnessed by this new class of drugs. Unlike adenosine, acadesine acts specifically at sites of ischemia and is therefore void of the systemic hemodynamic effects that may complicate adenosine the…

  57. 80.

    Tsogbadrakh B, Ryu H, Ju KD, Lee J, et al. · Biochemical and biophysical research communications · 2019 · PMID 30616891

    Cisplatin causes acute kidney injury (AKI) through proximal tubular injury. We investigated the protective effect of the adenosine monophosphate protein kinase (AMPK) activator 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) against cisplatin-induced AKI. We investigated whether the AMP-kinase activator AICAR ameliorates cisplatin-induced AKI through the JAK/STAT/SOCS pathway. Male Sprague-Dawley (SD) rats were randomly divided into four groups: control, AICAR, cisplatin, and cisplatin + A…

  58. 81.

    Liu J, Liang L, Li X, Peng YL, et al. · Biotechnology letters · 2021 · PMID 33788127

    To investigate the efficacy and safety of the AMPK activator AICAR alone or in combination with decitabine on myelodysplastic syndromes (MDS). p-AMPK (Thr172) expression was lower in MDS samples than in healthy donors. AMPK agonist AICAR inhibited the proliferation of MDS cell lines (SKM1 and MDS-L) (P < 0.05). The results from flow cytometry suggested that AICAR induced G0/G1 phase arrest and apoptosis through inducing DNA damage, as confirmed by immunofluorescence analysis in MDS cell lines. A…

  59. 82.

    Ahmad I, Molyvdas A, Jian MY, Zhou T, et al. · The European respiratory journal · 2021 · PMID 34049949

    We investigated the mechanisms by which N1-(β-d-ribofuranosyl)-5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), an activator of AMP-activated protein kinase (AMPK), decreases lung injury and mortality when administered to mice post exposure to bromine gas (Br We exposed male C57BL/6 mice and heme oxygenase-1 (HO-1)-deficient (HO-1 There was a marked downregulation of phosphorylated AMPK and LKB1 in lung tissues and in L2 and H441 cells post exposure. AICAR increased survival in C57BL/6 but…

  60. 83.

    Tsuchida A, Liu GS, Mullane K, Downey JM · Cardiovascular research · 1993 · PMID 8458021

    The aim was to test the hypothesis that adenosine A1 receptor activation triggers the cardioprotective effects of ischaemic preconditioning, by determining whether pretreatment with acadesine (5-amino-4-imidazolecarboxamide riboside), an agent which increases cardiac adenosine level during ischaemia, could alter the threshold for preconditioning. A branch of the left coronary artery of rabbit hearts was occluded for 30 min and reperfused for 3 h. Infarct size and risk zone size were determined w…

  61. 84.

    Douillet DC, Pinson B, Ceschin J, Hürlimann HC, et al. · The Journal of biological chemistry · 2019 · PMID 30478173

    5-Aminoimidazole-4-carboxamide 1-β-d-ribofuranoside (AICAR, or acadesine) is a precursor of the monophosphate derivative 5-amino-4-imidazole carboxamide ribonucleoside 5'-phosphate (ZMP), an intermediate in

  62. 85.

    Bergeron R, Previs SF, Cline GW, Perret P, et al. · Diabetes · 2001 · PMID 11334411

    Activation of AMP-activated protein kinase (AMPK) with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofurano-side (AICAR) increases glucose transport in skeletal muscle via an insulin-independent pathway. To examine the effects of AMPK activation on skeletal muscle glucose transport activity and whole-body carbohydrate and lipid metabolism in an insulin-resistant rat model, awake obese Zuckerfa/fa rats (n = 26) and their lean (n = 23) littermates were infused for 90 min with AICAR, insulin, or sali…

  63. 86.

    Sano K, Kawashima M, Ito A, Inaba T, et al. · Investigative ophthalmology & visual science · 2014 · PMID 24876288

    To investigate the effects of exercise on tear secretion in type 2 diabetic mice, and to investigate the effect of the adenosine monophosphate-activated protein kinase (AMPK) activator 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR). Heterozygous controls (db/m; m Lepr(db)) and type 2 diabetic mice (db/db; Lepr(db)) either underwent forced treadmill exercise training 5 days a week or remained sedentary for 8 weeks. Tear secretion volume was measured by cotton threads for 30 seconds pre- an…

  64. 87.

    Wu Y, Qi Y, Liu H, Wang X, et al. · Molecular and cellular biochemistry · 2016 · PMID 26497305

    The aim of the present study was to determine the effect of AICAR, an AMPK activator, on apoptosis in gastric carcinoma cells (SGC-7901) with or without 5-fluorouracil (5-FU). SGC-7901 cells were treated with AICAR (0.2-5 mM, for 24-48 h) with or without 5-FU. Cell viability was determined using MTT assay, while apoptosis were measured through the evaluation of active caspase-3 activity and DNA fragmentation. Real-time PCR was employed to determine the expression of tumor suppressor and multi-dr…

  65. 88.

    Wu JJ, Wei B, Ding YH, Deng ZK, et al. · Zhongguo shi yan xue ye xue za zhi · 2016 · PMID 26913390

    To investigate the effects of AMPK agonist Acadesine (AICAR) on growth inhibition of K562 cells and their sensitivity to imatinib (IM). K562 cells were cultured with different concentrations of AICAR alone or its combination with IM for 48 hours, the CCK-8 assay was used to detect cell proliferation, the cell cycle distribution and apoptosis were analyzed by flow cytometry. The expression levels of Cyclin D1, Cyclin E1 and Caspase 3 protein were determined by Western blot. AICAR inhibited the pr…

  66. 89.

    Agarwal S, Bell CM, Rothbart SB, Moran RG · The Journal of biological chemistry · 2015 · PMID 26391395

    The key sensor of energy status in mammalian cells, AMP-activated protein kinase (AMPK), can also be activated by the AMP analog aminoimidazolecarboxamide nucleoside monophosphate (ZMP) generated directly from aminoimidazolecarboxamide ribonucleoside (AICAR) or from inhibition of purine synthesis by the antifolate pemetrexed (PTX), a drug used extensively in the treatment of lung cancers. Despite this common mechanism, signaling downstream of AMPK activated by PTX or AICAR differed. AICAR-activa…

  67. 90.

    Zhang TG, Ikejima T, Hayashi T, Zhao J, et al. · Journal of applied toxicology : JAT · 2017 · PMID 28556920

    Isoniazid (INH) is a first-line antituberculosis drug that is adversely associated with hepatotoxicity. Recently, impairment of mitochondrial homeostasis involved in this side effect has been noticed. Mitochondrial homeostasis is achieved by the balance between the generation of functional mitochondria by biogenesis and elimination of dysfunctional mitochondria by autophagy. AMP-activated protein kinase (AMPK) can maintain mitochondrial stability through positive control of these two processes.…

  68. 91.

    Zarkin AK, Elkins PD, Gilbert A, Jester TL, et al. · Journal of labelled compounds & radiopharmaceuticals · 2018 · PMID 29902835

    5-Aminoimidazole-4-carboxamide-1-β-D-[

  69. 92.

    Ceschin J, Saint-Marc C, Laporte J, Labriet A, et al. · The Journal of biological chemistry · 2014 · PMID 24778186

    5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAr) is the precursor of the active monophosphate form (AICAR), a small molecule with potent anti-proliferative and low energy mimetic properties. The molecular bases for AICAR toxicity at the cellular level are poorly understood. Here, we report the isolation and characterization of several yeast AICAr-hypersensitive mutants. Identification of the cognate genes allowed us to establish that thiamine transporters Thi7 and Thi72 can efficientl…

  70. 93.

    Andris F, Denanglaire S, Baus E, Rongvaux A, et al. · Journal of immunology (Baltimore, Md. : 1950) · 2011 · PMID 21248260

    Adjuvant formulations boost humoral responses by acting through several, yet incompletely elucidated pathways. In this study, we show that oligomycin or 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside (AICAR) enhances Ab production when coinjected with T cell-dependent Ags. Oligomycin and AICAR lead to intracellular ATP reduction, suggesting that metabolic stress could be sensed by immune cells and leads to increased humoral responses. AICAR promotes IL-4 and IL-21 by naive Th cells but does…

  71. 94.

    Tanida M, Yamamoto N · Neuroscience letters · 2011 · PMID 21893163

    In this study, we examined the effect of intracerebroventricular (ICV) injection of 5-aminoimidazole-4-carboxamide 1-beta-d-ribofuranoside (AICAR), an AMP-activated protein kinase (AMPK) activator, or compound C (CC), an AMPK inhibitor, on the activity of sympathetic nerves innervating the adrenal gland and kidney in urethane-anesthetized rats to elucidate the role of AMPK in sympathetic nervous system function. We found that an ICV injection of AICAR or CC significantly stimulated renal sympath…

  72. 95.

    Sung MS, Li Z, Cui L, Choi JS, et al. · Investigative ophthalmology & visual science · 2015 · PMID 26024098

    To investigate the efficacy of topical 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) in a mouse model of experimental dry eye (EDE). Eye drops consisting of 0.001% or 0.01% AICAR, 0.05% cyclosporine A (CsA), or balanced salt solution (BSS) were applied for the treatment of EDE. Tear volume, tear film break-up time (BUT), and corneal fluorescein staining scores were measured 10 days after treatment. Levels of interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α, interferon (IFN)…

  73. 96.

    Al-Khalili L, Krook A, Zierath JR, Cartee GD · American journal of physiology. Endocrinology and metabolism · 2004 · PMID 15149951

    Exposing isolated rat skeletal muscle to 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside [AICAR, a pharmacological activator of AMP-activated protein kinase (AMPK)] plus serum leads to a subsequent increase in insulin-stimulated glucose transport (Fisher JS, Gao J, Han DH, Holloszy JO, and Nolte LA. Am J Physiol Endocrinol Metab 282: E18-E23, 2002). Our goal was to determine whether preincubation of primary human skeletal muscle cells with human serum and AICAR (Serum+AICAR) would also in…

  74. 97.

    Dolinar K, Jan V, Pavlin M, Chibalin AV, et al. · American journal of physiology. Cell physiology · 2018 · PMID 30230919

    AMP-activated kinase (AMPK) is a major regulator of energy metabolism and a promising target for development of new treatments for type 2 diabetes and cancer. 5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR), an adenosine analog, is a standard positive control for AMPK activation in cell-based assays. Some broadly used cell culture media, such as minimal essential medium α (MEMα), contain high concentrations of adenosine and other nucleosides. We determined whether such media alter AI…

  75. 98.

    Dembitz V, Tomic B, Kodvanj I, Simon JA, et al. · The Journal of biological chemistry · 2019 · PMID 31431503

    Metabolic pathways play important roles in proliferation and differentiation of malignant cells. 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAr), a precursor in purine biosynthesis and a well-established activator of AMP-activated protein kinase (AMPK), induces widespread metabolic alterations and is commonly used for dissecting the role of metabolism in cancer. We have previously reported that AICAr promotes differentiation and inhibits proliferation of myeloid leukemia cells. Here, using…

  76. 99.

    Hinkle JS, Rivera CN, Vaughan RA · Biochimie · 2022 · PMID 34798200

    Type 2 diabetes is characterized by reduced insulin sensitivity, elevated blood metabolites, and reduced mitochondrial metabolism. Insulin resistant populations often exhibit reduced expression of genes governing mitochondrial metabolism such as peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α). Interestingly, PGC-1α regulates the expression of branched-chain amino acid (BCAA) metabolism, and thus, the consistently observed increased circulating levels of BCAA in diab…

  77. 100.

    Ravel-Chapuis A, Fahmi C, Gobin J, Jasmin BJ · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024 · PMID 39611312

    Multiple signaling pathways have been reported to be altered in Myotonic Dystrophy type 1 (DM1) skeletal muscle, contributing to pathogenicity. In particular, previous work established that AMPK signaling, a key sensor of energy metabolism, is repressed in DM1 mouse muscle and that activating AMPK through exercise and/or with pharmacological activators is beneficial for the DM1 muscle phenotype. Here, we explored the effects of a newer, more specific allosteric AMPK activator acting directly on…

  78. 101.

    Idrovo JP, Yang WL, Jacob A, Aziz M, et al. · Molecular medicine (Cambridge, Mass.) · 2015 · PMID 25611433

    Intestinal ischemia and reperfusion (I/R) is encountered in various clinical conditions and contributes to multiorgan failure and mortality as high as 60% to 80%. Intestinal I/R not only injures the intestine, but affects remote organs such as the lung leading to acute lung injury. The development of novel and effective therapies for intestinal I/R are critical for the improvement of patient outcome. AICAR (5-aminoimidazole-4-carboxyamide ribonucleoside) is a cell-permeable compound that has bee…

  79. 102.

    Wang H, Zheng A, Thorley D, Arias EB, et al. · Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme · 2024 · PMID 38181403

    We assessed the effects of two levels of calorie restriction (CR; eating either 15% or 35% less than ad libitum, AL, food intake for 8 weeks) by 24-month-old female and male rats on glucose uptake (GU) and phosphorylation of key signaling proteins (Akt; AMP-activated protein kinase, AMPK; Akt substrate of 160 kDa, AS160) measured in isolated skeletal muscles that underwent four incubation conditions (without either insulin or AICAR, an AMPK activator; with AICAR alone; with insulin alone; or wit…

  80. 103.

    Bradley EA, Zhang L, Genders AJ, Richards SM, et al. · Cardiovascular diabetology · 2015 · PMID 26194188

    Insulin-induced microvascular recruitment is important for optimal muscle glucose uptake. 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR, an activator of AMP-activated protein kinase), can also induce microvascular recruitment, at doses that do not acutely activate glucose transport in rat muscle. Whether low doses of AICAR can augment physiologic insulin action is unknown. In the present study we used the euglycemic hyperinsulinemic clamp to assess whether insulin action is augmente…

  81. 104.

    Rao E, Zhang Y, Li Q, Hao J, et al. · Oncotarget · 2016 · PMID 27177226

    As a master metabolic sensor, AMP-activated protein kinase (AMPK) is involved in different fundamental cellular processes. Regulation of AMPK activity either by agonists (e.g., AICAR) or by antagonists (e.g., Compound C) has been widely employed to study the physiological functions of AMPK. However, mounting evidence indicates AMPK-independent effects for these chemicals and how they regulate immune cell functions remains largely unknown. Herein, using T cells from AMPK conditional knockout mice…

  82. 105.

    Marangos PJ, Loftus T, Wiesner J, Lowe T, et al. · Epilepsia · 1990 · PMID 2344840

    Homocysteine thiolactone (HTL) elicits seizures in mice at a dose of 850 mg/kg (95-100% of animals) with an average latency time of 19.5 min. These seizures are reversed by both 5' N-ethylcarboximide adenosine (NECA) and flunitrazepam, with respective ED50 doses of 0.025 and 0.20 mg/kg. NECA was approximately four-fold more potent as an inhibitor of HTL-induced seizures than of seizures induced by pentylenetetrazol (PTZ, 75 mg/kg). Flunitrazepam was equipotent in both seizure paradigms. The puri…

  83. 106.

    Leick L, Fentz J, Biensø RS, Knudsen JG, et al. · American journal of physiology. Endocrinology and metabolism · 2010 · PMID 20628026

    We tested the hypothesis that repeated activation of AMP-activated protein kinase (AMPK) induces mitochondrial and glucose membrane transporter mRNA/protein expression via a peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha)-dependent mechanism. Whole body PGC-1alpha-knockout (KO) and littermate wild-type (WT) mice were given either single or repeated subcutaneous injections of the AMPK activator AICAR or saline. Skeletal muscles were removed either 1 or 4 h after t…

  84. 107.

    LaRosa C, Downs SM · Molecular reproduction and development · 2005 · PMID 15570612

    The present study was carried out to assess the possible role of mitogen-activated protein kinase (MAPK) in the meiosis-inducing action of the AMP-activated protein kinase (AMPK) activator, 5-aminoimidazole-4-carboxamide 1-beta-ribofuranoside (AICAR). Cumulus cell-enclosed oocytes (CEO) or denuded oocytes (DO) from immature, eCG-primed mice were cultured 4 hr in Eagle's minimum essential medium containing dbcAMP plus increasing concentrations of AICAR or okadaic acid (OA). OA is a phosphatase in…

  85. 108.

    Zhang WC, Skiados N, Aftab F, Moreno C, et al. · Cancer gene therapy · 2022 · PMID 35840668

    In EGFR-mutant lung cancer, drug-tolerant persister cells (DTPCs) show prolonged survival when receiving EGFR tyrosine kinase inhibitor (TKI) treatments. They are a likely source of drug resistance, but little is known about how these cells tolerate drugs. Ribonucleic acids (RNAs) molecules control cell growth and stress responses. Nucleic acid metabolism provides metabolites, such as purines, supporting RNA synthesis and downstream functions. Recently, noncoding RNAs (ncRNAs), such as microRNAs…

  86. 109.

    Fisher JS, Ju JS, Oppelt PJ, Smith JL, et al. · American journal of physiology. Endocrinology and metabolism · 2005 · PMID 16030062

    We hypothesized that AMP-activated protein kinase-related kinase 5 (ARK5)/novel kinase family 1 (NUAK1), an AMP-activated protein kinase (AMPK)-related kinase that has been found to be stimulated by protein kinase B (Akt), would be expressed in rat skeletal muscle and activated by electrically elicited contractions, 5-aminoimidazole-4-carboxamide-1-beta-d-ribofuranoside (AICAR), or insulin. We verified expression of ARK5 in muscle through RT-PCR and Western blot. Cross-reactivity of ARK5 immunop…

  87. 110.

    Kobilo T, Yuan C, van Praag H · Learning & memory (Cold Spring Harbor, N.Y.) · 2011 · PMID 21245211

    Physical activity improves learning and hippocampal neurogenesis. It is unknown whether compounds that increase endurance in muscle also enhance cognition. We investigated the effects of endurance factors, peroxisome proliferator-activated receptor δ agonist GW501516 and AICAR, activator of AMP-activated protein kinase on memory and neurogenesis. Mice were injected with GW for 7 d or AICAR for 7 or 14 d. Two weeks thereafter mice were tested in the Morris water maze. AICAR (7 d) and GW improved…

  88. 111.

    Nie J, Liu A, Tan Q, Zhao K, et al. · Biochemical and biophysical research communications · 2017 · PMID 27847321

    AICAR (5-Aminoimidazole-4-carboxamide riboside or acadesine) is an AMP-activated protein kinase (AMPK) agonist, its activity in human gallbladder cancer cells was evaluated here. We show that AICAR provoked significant apoptosis in human gallbladder cancer cell lines (Mz-ChA-1, QBC939 and GBC-SD) and primary gallbladder cancer cells. AICAR-induced cytotoxicity in gallbladder cancer cells appears independent of AMPK activation. Inhibition of AMPK, via AMPKα shRNA knockdown or dominant negative mu…

  89. 112.

    Yu H, Liu Q, Chen G, Huang L, et al. · International immunopharmacology · 2022 · PMID 35217431

    Extensive vascular endothelial dysfunction usually occurs in sepsis, resulting in high mortality. The purpose of this study was therefore to investigate the role of AMP-dependent protein kinase (AMPK) in the aortic endothelial dysfunction of early sepsis in mice, and the relationship between AMPK and Sirtuin3 (SIRT3). Cecal ligation and puncture (CLP) surgery was performed to establish a mouse sepsis model, and human umbilical vein endothelial cells (HUVECs) were treated with lipopolysaccharide…

  90. 113.

    Zheng D, MacLean PS, Pohnert SC, Knight JB, et al. · Journal of applied physiology (Bethesda, Md. : 1985) · 2001 · PMID 11509501

    Skeletal muscle GLUT-4 transcription in response to treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside (AICAR), a known activator of AMP-activated protein kinase (AMPK), was studied in rats and mice. The increase in GLUT-4 mRNA levels in response to a single subcutaneous injection of AICAR, peaked at 13 h in white and red quadriceps muscles but not in the soleus muscle. The mRNA level of chloramphenicol acyltransferase reporter gene which is driven by 1,154 or 895 bp of the hu…

  91. 114.

    Dembitz V, Lalic H, Visnjic D · Cell death discovery · 2017 · PMID 28975042

    Pharmacological modulators of AMP-dependent kinase (AMPK) have been suggested in treatment of cancer. The biguanide metformin and 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) have been reported to inhibit proliferation of solid tumors and hematological malignancies, but their role in differentiation is less explored. Our previous study demonstrated that AICAR alone induced AMPK-independent expression of differentiation markers in monocytic U937 leukemia cells, and no such effects were o…

  92. 115.

    Viglino C, Foglia B, Montessuit C · Pflugers Archiv : European journal of physiology · 2019 · PMID 31152240

    The stimulation of glucose transport by metabolic stress is an important determinant of myocardial susceptibility to ischemia and reperfusion injury. Stimulation of glucose transport is markedly impaired in cardiomyocytes chronically exposed to excess free fatty acids (FFA), as occurs in vivo in type 2 diabetes. To determine whether chronic low-grade activation of AMP-activated kinase (AMPK) improves substrate metabolism in cardiomyocytes exposed to FFA, isolated cultured cardiomyocytes were exp…

  93. 116.

    Carrasco-Chaumel E, Roselló-Catafau J, Bartrons R, Franco-Gou R, et al. · Journal of hepatology · 2005 · PMID 16085333

    Hepatic steatosis is a risk factor for transplantation. We examined the role of AMP-activated protein kinase (AMPK) and nitric oxide (NO) in the benefits of preconditioning in steatotic liver transplantation. Steatotic liver transplantation with or without preconditioning was induced in Zucker rats. The activities of AMPK and NO synthase (NOS) were measured and altered pharmacologically. Preconditioning or AMPK activation with aminoimidazole-4-carboxamide ribonucleoside (AICAR) increased AMPK an…

  94. 117.

    Zineldeen DH, Tahoon NM, Sarhan NI · International journal of molecular sciences · 2023 · PMID 36834782

    Non-alcoholic fatty liver disease (NAFLD) is a global health problem characterized by altered lipid and redox homeostasis, mitochondrial dysfunction, and endoplasmic reticulum (ER) stress. The AMP-dependent kinase (AMPK) agonist 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) has been shown to improve the outcome of NAFLD in the context of AMPK activation, yet the underlying molecular mechanism remains obscure. This study investigated the potential mechanism(s) of AICAR to attenuate NAFLD…

  95. 118.

    Hayashi T, Hirshman MF, Kurth EJ, Winder WW, et al. · Diabetes · 1998 · PMID 9703344

    The intracellular signaling proteins that lead to exercise-stimulated glucose transport in skeletal muscle have not been identified, although it is clear that there are separate signaling mechanisms for exercise- and insulin-stimulated glucose transport. We have hypothesized that the 5'AMP-activated protein kinase (AMPK) functions as a signaling intermediary in exercise-stimulated glucose uptake. This hypothesis was based on recent studies showing the following: 1) muscle contraction increases A…

  96. 119.

    Sánchez J, Nozhenko Y, Palou A, Rodríguez AM · Molecular nutrition & food research · 2013 · PMID 23650203

    We aimed to study the effects of free fatty acids (FFAs) alone and combined with the exercise mimetics adrenaline and 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) in the production of IL6, IL15 and Irisin in muscle cells, using a time-sequential model. Differentiated C2C12 myotubes were treated with FFA, adrenaline or AICAR alone for 0, 1, 3, 8, 12 and 24 h and with double or triple combinations for 0, 3 and 24 h. Levels of mRNA in cells and protein in the medium were measured. Adrenali…

  97. 120.

    Tripathi V, Jaiswal P, Assaiya A, Kumar J, et al. · Current cancer drug targets · 2022 · PMID 35135451

    Triple-negative breast cancer (TNBC) is known for Warburg effect and defects in the mitochondria. AMP-dependent kinase (AMPK) activates the downstream transcription factors PGC-1α, PGC-1β, or FOXO1, which participate in mitochondrial biogenesis. 5- aminoimidazole-4-carboxamide riboside (AICAR) is an analog of adenosine monophosphate and is a direct activator of AMPK. In the present study, we have made an attempt to understand the influence of AICAR on TNBC cells, MDA-MB-231, and the underlying c…

  98. 121.

    Dedert CJ, Bagdady KR, Fisher JS · Current issues in molecular biology · 2023 · PMID 37886951

    Metabolic stress in skeletal muscle cells causes sustained metabolic changes, but the mechanisms of the prolonged effects are not fully known. In this study, we tested C2C12 cells with the AMP-activated protein kinase (AMPK) stimulator AICAR and measured the changes in the metabolic pathways and signaling kinases. AICAR caused an acute increase in the phosphorylation of the AMPK target ULK1, the mTORC1 substrate S6K, and the mTORC2 target Akt. Intriguingly, prior exposure to AICAR only decreased…

  99. 122.

    Peairs A, Radjavi A, Davis S, Li L, et al. · Clinical and experimental immunology · 2009 · PMID 19438609

    Recent reports show that 5-amino-4-imidazole carboxamide riboside (AICAR), a pharmacological activator of AMP-activated protein kinase (AMPK), inhibits the lipopolysaccharide (LPS)-induced production of proinflammatory cytokines. MRL/MPJ-Fas(lpr) (MRL/lpr) mice show an intrinsic decreased threshold for the production of inflammatory mediators when stimulated. In our current studies, we sought to determine if AMPK activation would inhibit inflammatory mediator production in stimulated kidney mesa…

  100. 123.

    Spangenburg EE, Jackson KC, Schuh RA · Journal of physiology and biochemistry · 2013 · PMID 23813470

    Activation of 5' adenosine monophosphate-activated protein kinase (AMPK) with aminoimidazole carboxamide ribonucleotide (AICAR) increases skeletal muscle glucose uptake and fatty acid oxidation. The purpose of these experiments was to utilize AICAR to enhance palmitate consumption by mitochondria in cultured skeletal muscle cells. In these experiments, we treated C2C12 myotubes or adult single skeletal muscle fibers with varying concentrations of AICAR for different lengths of time. Surprisingly…

  101. 124.

    Jing M, Cheruvu VK, Ismail-Beigi F · American journal of physiology. Cell physiology · 2008 · PMID 18701654

    AMP-activated protein kinase (AMPK) plays a critical role in the stimulation of glucose transport in response to hypoxia and inhibition of oxidative phosphorylation. In the present study, we examined the signaling pathway(s) mediating the glucose transport response following activation of AMPK. Using mouse fibroblasts of AMPK wild type and AMPK knockout, we documented that the expression of AMPK is essential for the glucose transport response to both azide and 5-aminoimidazole-4-carboxamide-1-be…

  102. 125.

    Suzuki J, Yoshimura T, Simeonova M, Takeuchi K, et al. · Investigative ophthalmology & visual science · 2012 · PMID 22562518

    To investigate the anti-inflammatory effect of an adenosine monophosphate (AMP) analog, aminoimidazole carboxamide ribonucleotide (AICAR), in experimental autoimmune uveoretinitis (EAU). C57BL/6 mice were injected daily with AICAR (200 mg/kg, intraperitoneally [IP]) from day 0, the day of interphotoreceptor retinoid-binding protein (IRBP) immunization, until day 21. The severity of uveitis was assessed clinically and histopathologically. T-cell proliferation and cytokine production of IFN-γ, IL-…

  103. 126.

    Kim JE, Ahn MW, Baek SH, Lee IK, et al. · Bone · 2008 · PMID 18502715

    Osteoblast apoptosis reduces bone mineral density. Apoptosis can be induced in a variety of cells by palmitate, which is one of the most common saturated fatty acids in dietary fat. The AMPK activator, AICAR, has been shown to inhibit palmitate-induced apoptosis. However, the role of palmitate in osteoblast apoptosis is currently unknown. This study examined whether palmitate could induce apoptosis in osteoblasts, and if so, whether AICAR could alleviate palmitate-induced apoptosis. Palmitate re…

  104. 127.

    Liu F, Jin R, Liu X, Huang H, et al. · Oncotarget · 2016 · PMID 26506235

    We analyzed the mechanism underlying 5-aminoimidazole-4-carboxamide riboside (AICAR) mediated apoptosis in LKB1-null non-small cell lung cancer (NSCLC) cells. Metabolic profile analysis revealed depletion of the intracellular pyrimidine pool after AICAR treatment, but uridine was the only nucleotide precursor capable of rescuing this apoptosis, suggesting the involvement of RNA metabolism. Because half of RNA transcription in cancer is for pre-ribosomal RNA (rRNA) synthesis, which is suppressed…

  105. 128.

    Morishita M, Kawamoto T, Hara H, Onishi Y, et al. · International journal of oncology · 2017 · PMID 27878239

    The AMP-activated protein kinase (AMPK) activator 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) modulates cellular energy metabolism, and promotes mitochondrial proliferation and apoptosis. Previous studies have shown that AICAR has anticancer effects in various cancers, however the roles of AMPK and/or the effects of AICAR on osteosarcoma have not been reported. In the present study, we evaluated the effects of AICAR on tumor growth and mitochondrial apoptosis in human osteosarcoma both…

  106. 129.

    Saint-Marc C, Hürlimann HC, Daignan-Fornier B, Pinson B · Current genetics · 2015 · PMID 25893566

    Previous genetic analyses showed phenotypic interactions between 5-amino-4-imidazole carboxamide ribonucleotide 5'-phosphate (AICAR) produced from the purine and histidine pathways and methionine biosynthesis. Here, we revisited the effect of AICAR on methionine requirement due to AICAR accumulation in the presence of the fau1 mutation invalidating folinic acid remobilization. We found that this methionine auxotrophy could be suppressed by overexpression of the methionine synthase Met6 or by del…

  107. 130.

    Longnus SL, Wambolt RB, Parsons HL, Brownsey RW, et al. · American journal of physiology. Regulatory, integrative and comparative physiology · 2003 · PMID 12626360

    We tested the hypothesis that activation of AMP-activated protein kinase (AMPK) promotes myocardial glycogenolysis by decreasing glycogen synthase (GS) and/or increasing glycogen phosphorylase (GP) activities. Isolated working hearts from halothane-anesthetized male Sprague-Dawley rats perfused in the absence or presence of 0.8 or 1.2 mM 5-aminoimidazole-4-carboxamide 1-beta-d-ribofuranoside (AICAR), an adenosine analog and cell-permeable activator of AMPK, were studied. Glycogen degradation was…

  108. 131.

    Galiñanes M, Zhai X, Bullough D, Mullane KM, et al. · The Journal of thoracic and cardiovascular surgery · 1995 · PMID 7564443

    Acadesine (AICAr: 5-amino-4-imidazole carboxamide riboside) has been shown to afford sustained protection against injury during ischemia and reperfusion. The present studies used the heterotopically transplanted rat heart to assess the protective properties of two new acadesine analogs: GP-1-468 and GP-1-668. Hearts were excised, arrested with a 2-minute infusion of cardioplegic solution, and subjected to 4 hours of global ischemia (20 degrees C) with cardioplegic reinfusion for 2 minutes every…

  109. 132.

    Du L, Yang F, Fang H, Sun H, et al. · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019 · PMID 30702927

    It has been shown that 5-amino-4-imidazolecarboxamide riboside (AICAr) can inhibit cell proliferation and induce apoptosis in childhood acute lymphoblastic leukemia (ALL) cells. Although AICAr could regulate cellular energy metabolism by activating AMPK, the cytotoxic mechanisms of AICAr are still unclear. Here, we knocked out TP53 or PRKAA1 gene (encoding AMPKα1) in NALM-6 and Reh cells by using the clustered regularly interspaced short palindromic repeats/Cas9 system and found that AICAr-induc…

  110. 133.

    Xiang RL, Mei M, Cong X, Li J, et al. · Journal of molecular cell biology · 2014 · PMID 25503106

    Tight junction plays an important role in mediating paracellular permeability in epithelia. We previously found that activation of AMP-activated protein kinase (AMPK) increased saliva secretion by modulating paracellular permeability in submandibular glands. However, the molecular mechanisms underlying AMPK-modulated paracellular permeability are unknown. In this study, we found that AICAR, an AMPK agonist, increased saliva secretion in the isolated rat submandibular glands, decreased transepith…

  111. 134.

    Verma P, Kar B, Varshney R, Roy P, et al. · The FEBS journal · 2017 · PMID 29063699

    The 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase/inosine monophosphate (IMP) cyclohydrolase (ATIC) catalyzes final two steps of purine nucleotide de novo biosynthetic pathway. This study reports the characterization of ATIC from Staphylococcus lugdunensis (SlugATIC). Apart from kinetic analysis and a detailed biophysical characterization of SlugATIC, the role of ATIC in cell proliferation has been demonstrated for the first time. The purified recombinant SlugATIC and its…

  112. 135.

    Mukhopadhyay S, Chatterjee A, Kogan D, Patel D, et al. · Cell cycle (Georgetown, Tex.) · 2015 · PMID 26323019

    mTOR - the mammalian/mechanistic target of rapamycin - has been implicated as a key signaling node for promoting survival of cancer cells. However, clinical trials that have targeted mTOR with rapamycin or rapamycin analogs have had minimal impact. In spite of the high specificity of rapamycin for mTOR, the doses needed to suppress key mTOR substrates have proved toxic. We report here that rapamycin when combined with AICAR - a compound that activates AMP-activated protein kinase makes rapamycin…

  113. 136.

    Bergeron R, Russell RR, Young LH, Ren JM, et al. · The American journal of physiology · 1999 · PMID 10329989

    The effect of AMP-activated protein kinase (AMPK) activation on skeletal muscle glucose metabolism was examined in awake rats by infusing them with 5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside (AICAR; 40 mg/kg bolus and 7.5 mg. kg-1. min-1 constant infusion) along with a variable infusion of glucose (49.1 +/- 2.4 micromol. kg-1. min-1) to maintain euglycemia. Activation of AMPK by AICAR caused 2-deoxy-D-[1,2-3H]glucose (2-DG) uptake to increase more than twofold in the soleus and the l…

  114. 137.

    Bazurto JV, Heitman NJ, Downs DM · Journal of bacteriology · 2015 · PMID 26100042

    In Salmonella enterica, the thiamine biosynthetic intermediate 5-aminoimidazole ribotide (AIR) can be synthesized de novo independently of the early purine biosynthetic reactions. This secondary route to AIR synthesis is dependent on (i) 5-amino-4-imidazolecarboxamide ribotide (AICAR) accumulation, (ii) a functional phosphoribosylaminoimidazole-succinocarboxamide (SAICAR) synthetase (PurC; EC 6.3.2.6), and (iii) methionine and lysine in the growth medium. Studies presented here show that AICAR i…

  115. 138.

    Suzuki T, Yamamoto N, Choi JH, Takano T, et al. · Scientific reports · 2016 · PMID 27991529

    "Fairy rings" resulting from fungus-stimulated plant growth occur all over the world. In 2010, 2-azahypoxanthine (AHX) from a fungus Lepista sordida was identified as the "fairy" that stimulates plant growth. Furthermore, 2-aza-8-oxohypoxanthine (AOH) was isolated as a common metabolite of AHX in plants, and the endogenous existence of AHX and AOH in plants was proved. The structure of AHX allowed us to hypothesize that AHX was derived from 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR).…

  116. 139.

    Cosseau C, Garnerone AM, Batut J · Molecular plant-microbe interactions : MPMI · 2002 · PMID 12059108

    AICAR, a purine-related metabolite, was recently shown to inhibit respiratory and nifA gene expression in Sino-rhizobium meliloti. Here, we demonstrate that AICAR has essentially no or little effect in a wild-type S. meliloti strain and inhibits respiratory and nitrogen fixation gene expression only in specific mutant backgrounds. We have analyzed in detail a mutant in which addition of AICAR inhibited fixK,fixN,fixT and nifA expression. The corresponding gene,fixM, is located just downstream of…

  117. 140.

    Ceschin J, Hürlimann HC, Saint-Marc C, Albrecht D, et al. · The Journal of biological chemistry · 2015 · PMID 26283791

    5-Aminoimidazole-4-carboxamide-1-β-D-ribofuranoside monophosphate (AICAR) is a natural metabolite with potent anti-proliferative and low energy mimetic properties. At high concentration, AICAR is toxic for yeast and mammalian cells, but the molecular basis of this toxicity is poorly understood. Here, we report the identification of yeast purine salvage pathway mutants that are synthetically lethal with AICAR accumulation. Genetic suppression revealed that this synthetic lethality is in part due…

  118. 141.

    Komatsu Y, Yanagisawa Y, Moriizumi M, Tsuchiya Y, et al. · Journal of biochemistry · 2016 · PMID 26590300

    The 5'-AMP-activated protein kinase (AMPK) functions as a cellular energy sensor. 5-Aminoimidazole-4-carboxyamide-1-β-D-ribofranoside (AICAR) is a chemical activator of AMPK. In the liver, AICAR suppresses expression of thephosphoenolpyruvate carboxykinase(PEPCK) gene. The rat enhancer of split- and hairy-related protein-2 (SHARP-2) is an insulin-inducible transcriptional repressor and its target is thePEPCKgene. In this study, we examined an issue of whether theSHARP-2gene expression is regulat…

  119. 142.

    Santidrián AF, González-Gironès DM, Iglesias-Serret D, Coll-Mulet L, et al. · Blood · 2010 · PMID 20664053

    5-Aminoimidazole-4-carboxamide riboside or acadesine (AICAR) induces apoptosis in chronic lymphocytic leukemia (CLL) cells. A clinical study of AICAR is currently being performed in patients with this disease. Here, we have analyzed the mechanisms involved in AICAR-induced apoptosis in CLL cells in which it activates its only well-known molecular target, adenosine monophosphate-activated protein kinase (AMPK). However, AMPK activation with phenformin or A-769662 failed to induce apoptosis in CLL…

  120. 143.

    Kim TB, Kim SY, Moon KA, Park CS, et al. · Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2007 · PMID 17877757

    Asthma can frequently be induced or exacerbated by respiratory viral infections. Oxidative stress might also play an essential role in the pathogenesis of allergic airway diseases, indicating that antioxidant therapy may have a potential effect in controlling allergic airway diseases. Recent studies showed that 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside (AICAR) has the potential ability to modulate NADPH oxidase activity, indicating the antioxidant activity of AICAR. This study inves…

  121. 144.

    Zhang C, Liu Z, Wang Y, Deng W, Wang H, Zhang J, Feng Q. · 2026 · PMID 41847319

    This study aims to explore the impact of microwave radiation on the electrophysiological functions of human-induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) and to focus on the critical role and underlying mechanism of autophagy in this process. The iPSC-CMs were irradiated with S-band microwaves at a power of 30 mw/cm<sup>2</sup>. Through techniques such as immunofluorescence, Western blotting, electrophysiological recording, scanning electron microscopy, and transcriptomic analy…

  122. 145.

    Liu R, Zheng W, Cai L, Xiao Q, Liu G, Jiang Y, He Z, Kang J. · 2025 · PMID 40607722

    Acadesine (AICAR) is a promising candidate for new drugs in Phase III clinical trials. The purpose of this study is to analyse the steps in the biosynthesis pathway of AICAR. Our previous study found that overexpression of <i>veA</i>, a gene encoding a global regulator, significantly increased AICAR production of endophytic <i>Fusarium solani</i> HB1-J1 and the anti-tumor activity of its extracts. Transcriptome and metabolome analysis of FsveA<sup>OE14</sup>, a <i>veA</i> overexpressing <i>F. so…

  123. 146.

    Chen Q, Wang J, Liu R, Li H, He Z, Kang J. · 2026 · PMID 41878508

    Endogenous AICAR (acadesine) demonstrates significant therapeutic potential as a phase III clinical agent for the treatment of adverse cardiovascular reactions to coronary artery bypass grafting and as a phase I/II clinical agent for chronic lymphocytic leukaemia. However, its biosynthetic mechanism remains poorly defined. Our previous study demonstrated that AICAR was significantly enriched in the <i>Fusarium solani</i> mutant <i>veA</i> <sup>OE14</sup>, which overexpressed the global regulator…

  124. 147.

    Tan LX, Zhang YY, Liu ZJ, Cao Y, Liu JJ, Mo MH, Liu T. · 2026 · PMID 41807727

    Germination and growth of biocontrol microorganisms in soil are often inhibited by soil fungistasis (SF), resulting in unsatisfactory control efficacy. Therefore, exploring mechanisms underlying SF is important for developing efficient biocontrol agents. Benzaldehyde has a strong fungistatic effect against the nematophagous fungus Arthrobotrys oligospora. Our transcriptome analysis suggested a fungistatic model by which benzaldehyde induces reactive oxygen species (ROS), leading to energy defici…

  125. 148.

    Wan T, Chen Z, Li J, Yuan X, Zheng M, Qin L, Zhang L, Hou T, Liu C, Li R. · 2025 · PMID 40082541

    Liver is an important target organ of ambient fine particulate matter (PM<sub>2.5</sub>). Numerous studies have shown that PM<sub>2.5</sub> exposure can cause liver lipid metabolism disorders and other liver damage in mammals. However, the impact of PM<sub>2.5</sub> on liver health during pregnancy, a sensitive life stage, remains understudied, and the underlying mechanisms are also unknown. Given the critical role of adenosine 5'-monophosphate activated protein kinase (AMPK) in regulating lipid…

  126. 149.

    Chen S, Sun Z, Liu N, Yang C, Li N, Li L, Wei C, Yan B, Gao H, Tan P, Mu H. · 2024

    The impacts of AMP-activated protein kinase (AMPK) activation by dietary acadesine (AICAR) on growth performance and muscle quality of large yellow croaker (Larimichthys crocea) fed a linseed oil-based diet (LO) were investigated by a 56-day feeding trial in this study. Fish (initial weight: 92.24 ± 0.30 g) were fed fish oil-based diet (FO), LO or LA (LO diet supplemented with 150 mg kg⁻¹ AICAR) with three replicates of each treatment. Results indicated that weight gain rate and specific growth…

  127. 150.

    Polet M, Van Eenoo P. · 2026 · PMID 41955491

    5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) is prohibited in sports according to the World Anti-Doping Agency (WADA). Currently, AICAR concentrations are measured during the initial testing procedure, and urine samples showing elevated levels are flagged as suspicious and forwarded for confirmation. Here, gas chromatography combustion isotope ratio mass spectrometry (GC-C-IRMS) is employed to distinguish endogenous from exogenous AICAR, as synthetic AICAR exhibits a different car…

  128. 151.

    Yang Z, Liu Y, Xu H, Yamane J, Hotta A, Fujibuchi W, Yamashita JK. · 2026 · PMID 42058906

    Pluripotent stem cells (PSCs) exist in either a "primed" state or a "naive" state. While several protocols are available to convert primed human PSCs (hPSCs) to the naive-state hPSCs, they often require multiple exogenous factors. Here, we show that the activation of AMP-activated protein kinase (AMPK) or its downstream p38 alone induces naive conversion. Primed hPSCs cultured with activated AMPK-p38 displayed key naive features, including naive marker expression, three-germ-layer differentiatio…

  129. 152.

    Huang Y, Lyu B, Tang K, Hu K. · 2025 · PMID 40964109

    <h4>Objective</h4>To elucidate the regulatory role and the underlying molecular mechanisms of serine/threonine protein kinase 1 (AKT1) in the lens epithelium of patients with age-related cataract (ARC).<h4>Methods</h4>1) Differentially expressed genes in ARC were screened using bioinformatics analysis (Genecard and GEO database GSE213546), and key genes were identified through functional enrichment analysis (KEGG and GO). 2) An oxidative stress model of lens epithelial cells was established by t…

  130. 153.

    Takahashi K, Kurokawa K, Kawaguchi R, Takeda H, Tsuji M. · 2026 · PMID 41932583

    Gut microbiota alterations are associated with the onset of depression; however, the underlying mechanisms remain unclear. Activation of hippocampal AMP-activated protein kinase (AMPK) in ulcerative colitis mice with disrupted gut microbiota balance produces antidepressant effects. However, the relationship between hippocampal AMPK and antibiotic treatment (ABX)-induced depression-like behavior remains unclear. Therefore, we aimed to investigate whether 5-aminoimidazole-4-carboxamide 1-β-d-ribof…

  131. 154.

    Zhang W, Wang J, Yang L, Shao Y, Peng H, Jiang L, Sheng L. · 2024 · PMID 39618181

    Cholestatic liver disease, caused by the accumulation of hazardous bile acids in the liver, may result in cirrhosis, fibrosis, or liver failure. Activation of sirtuin 6 (SIRT6) prevents cholestasis-associated pathological events, such as oxidative stress and mitochondrial biogenesis dysfunction, and inhibits bile acid synthesis to alleviate cholestatic liver injury. However, it remains uncertain which pathway mediates the therapeutic effect of SIRT6 in reducing cholestasis. Therefore, we treated…

  132. 155.

    Barnabé MA, Elliott J, Menzies-Gow NJ, Bailey SR, Bamford NJ, Chang YM, Gage MC. · 2026 · PMID 42161434

    <h4>Background</h4>Lamellar endoplasmic reticulum (ER) stress occurs in hyperinsulinemia-associated and sepsis-related laminitis. Adiponectin is associated with reduced laminitis risk and inhibits ER stress in other species.<h4>Objectives</h4>To induce ER stress in ex vivo equine lamellar cells using pharmacological agents. To determine whether co-treatment with adiponectin receptor agonists (ARAs) reduces ER stress.<h4>Study design</h4>In vitro.<h4>Methods</h4>Lamellar cells from n = 4-5 horses…

  133. 156.

    Imoto T, Ishizaka J, Tamura Y. · 2026 · PMID 41718390

    <b>Background</b>: AMP-activated protein kinase (AMPK) acts as a key energy sensor that negatively regulates skeletal muscle mass. Zinc is an essential trace element that is required for myogenic differentiation and protein synthesis, while zinc deficiency has been associated with muscle atrophy in vivo. However, how zinc status modulates AMPK activation itself or alters downstream responses to AMPK signaling in muscle cells remains unclear. <b>Methods</b>: C2C12 myotubes were cultured under zin…

  134. 157.

    Zhang J, Huang Y, Sun X, Chen X, Zhao X, Ran C, Liu B, Hao Y. · 2024 · PMID 39525593

  135. 158.

    Huang H, Tattersfield C, Jacas S, Karreci ES, Rumde A, Kelly J, Francey L, Subramanian B, Huang M, Ryback B, Schumacher V, Alper SL, Zsengellér ZK, Pollak MR, Friedman DJ. · 2026 · PMID 42101909

    <h4>Background</h4>13% of African Americans have a high risk APOL1 genotype, carrying two risk alleles (G1/G1, G1/G2 or G2/G2). The mechanisms underlying nephropathy caused by these APOL1 risk variant genotypes are not fully understood. Downstream of gene function, homeostatic maintenance of a complex and interconnected network of metabolites is essential for normal kidney function. However, this metabolic network can be rerouted by genetic changes or environmental insults, both of which can con…

  136. 159.

    Wang M, Kang Y, Zhang B, Zhang C, Li F, Jiang X, Li J, Chang D. · 2026 · PMID 41958127

    <h4>Objective</h4>To investigate the regulatory role of AMP-activated protein kinase (AMPK) activation in ferroptosis during lipopolysaccharide (LPS)-induced sepsis-associated acute kidney injury (SA-AKI) and its molecular mechanisms.<h4>Methods</h4>Thirty SPF male C57BL/6 mice were randomly assigned to the control group, LPS group, and LPS+AMPK activator (AICAR) group using a random number table method, with 10 mice per group. Mice in the LPS+AICAR group received an intraperitoneal injection of…

  137. 160.

    Wang Y, Wang W, Sun J, Zhou S, Ni L, Dong M, Wang X, Yuan Y, Wang J, Ren P, Fang W, Jin K. · 2026 · PMID 42031090

    Sepsis-associated acute kidney injury (SA-AKI) is closely linked to profound metabolic reprogramming and mitochondrial dysfunction, yet effective metabolic targeted therapies remain limited. In this study, we elucidated the molecular mechanism by which ethyl pyruvate (EP), an exogenous metabolic substrate, alleviates SA-AKI by regulating mitochondrial bioenergetics through the AMPK-mTOR-SIRT3 signaling pathway. Using a cecal ligation and puncture-induced SA-AKI mouse model and LPS-stimulated HK-…

  138. 161.

    Chi J, Wu N, Li P, Hu J, Cai H, Lin C, Lai Y, Yang H, Huang J, Li M, Xu L. · 2024 · PMID 38424223

    High mortality due to hygrothermal stress during heat waves is mostly linked to cardiovascular malfunction, the most serious of which are malignant arrhythmias. However, the mechanism associated with hygrothermal stress leading to malignant arrhythmias remains unclear. The energy metabolism regulated by liver kinase B1 (LKB1) and adenosine monophosphate-activated protein kinase (AMPK) and the electrical signaling based on gap junction protein, connexin43 (Cx43), plays important roles in the deve…

  139. 162.

    Alshuweishi Y, Binzomah Alghamdi F, Patrick K, Salt IP. · 2025 · PMID 41294864

    AMP-activated protein kinase (AMPK) is activated by reduced cellular energy charge and mimics the action of insulin in muscle by stimulating increased trafficking of GLUT4 to the plasma membrane. In contrast, we have previously reported that short-term activation of AMPK in adipocytes has no effect on glucose uptake. Whether prolonged AMPK activation influences adipocyte glucose uptake remains poorly characterised. To investigate the effect of sustained AMPK activation on glucose uptake in adipo…

  140. 163.

    Khorsandi L, Fakhredini F, Azandeh SS, Bijan-Nejad D, Karimi S, Rezaei-Tazangi F, Panahi A, Radmehr S. · 2025 · PMID 41640662

    <h4>Background</h4>Breast cancer, one of the most prevalent cancers, remains the leading cause of mortality worldwide. Dysregulation of autophagy and apoptosis regulators is closely associated with cancer progression. AMP-activated protein kinase (AMPK) plays a critical role in tumorigenesis by regulating these processes. This study aimed to investigate the anticancer effects of Morin and aminoimidazole carboxamide ribonucleotide (AICAR) on viability, apoptosis, and autophagy in <i>MCF-7</i> cel…

  141. 164.

    Ding B, Gui S, Wang X, Tao Y, Wang J, Su J, Li Y, Jiang Z, Tao L. · 2026 · PMID 41839915

  142. 165.

    Dayer D, Akbari-Jonoush Z, Mahdavi R, Amari A, Keshavarz-Zarjani A, Khorsandi L. · 2026 · PMID 41346764

    Prior studies have shown that conditioned media derived from Wharton's jelly mesenchymal stem cells (WJ-CM) have anti-cancer properties. This research investigated the impact of WJ-CM on HT-29 colorectal adenocarcinoma cells by examining autophagy biomarkers and the AMPK/mTOR pathway. The HT-29 cells were subjected to WJ-CM and an AMPK activator (AICAR). Autophagy and levels of AMPK and mTOR proteins were investigated. WJ-CM increased the expression of phosphorylated AMPK while reducing the leve…

  143. 166.

    Wang W, Wang S. · 2026 · PMID 41620890

    <h4>Background</h4>Hypertension is one of the most common chronic diseases in the world, affecting about a quarter of the adult population. Its complication, hypertensive myocardial infarction (HMI), has a complex pathological mechanism, involving myocardial ischemia, oxidative stress and microcirculation dysfunction.<h4>Objective</h4>This study investigated the cardioprotective mechanisms of nicorandil (Nic), particularly its effects on cardiac microcirculation through modulation of the Liver K…

  144. 167.

    Morgado JS, Machado IF, Rolo AP, Palmeira CM. · 2026 · PMID 41898462

    Metabolic dysfunction-associated fatty liver disease (MAFLD) has become the most prevalent chronic liver disorder worldwide, driven by metabolic dysfunction, excessive lipid accumulation, and progressive hepatocellular injury. A growing body of evidence identifies mitochondrial impairment as a central contributor to MAFLD pathogenesis and disease progression. Reduced oxidative capacity, elevated reactive oxygen species, and accumulation of dysfunctional mitochondria collectively exacerbate steat…

  145. 168.

    Guo YJ, Wu F, Gong MM, Wu WB, Lu FE, Wang DK. · 2026 · PMID 42126802

    <h4>Objective</h4>To investigate the therapeutic effects and molecular mechanisms of berberine (BBR) for non-alcoholic fatty liver disease (NAFLD) concomitant with type 2 diabetes mellitus (T2DM).<h4>Methods</h4>In vivo, 16 db/db mice were randomly assigned to the model group and the BBR group by a random number table method (n=8), with db/m mice serving as the control group. Mice were given BBR [100 mg/(kg·d)] or distilled water via gavage for 4 weeks. In vitro, 5-aminoimidazole-4-carboxyamide…

  146. 169.

    Biswas D, Espino-Gonzalez E, Ahwazi D, Freemantle JB, Ehrlich AM, Jomard C, Brorson J, Schou AN, Farup J, Gondin J, Just J, Foretz M, Treebak JT, Agerholm M, Sakamoto K. · 2026 · PMID 41325841

    <h4>Objectives</h4>Small-molecule activators targeting the allosteric drug and metabolite (ADaM) site of AMPK enhance insulin-independent glucose uptake in skeletal muscle and lower glucose in preclinical models of hyperglycemia. The regulatory AMPKγ subunit plays a central role in energy sensing. While the skeletal muscle-selective γ3 isoform is essential for AMP/ZMP-induced glucose uptake, it is dispensable for ADaM site-binding activators. We hypothesized that the predominant γ1 isoform is re…

  147. 170.

    Musial PT, Badtke PA, Zabielska-Kaczorowska MA. · 2025 · PMID 41226492

    Changes in the homeostatic balance between purine nucleotide synthesis, degradation, and salvage are caused by disruptions in ATP supply and/or demand in the heart. These disruptions may affect myocardial energetics and, consequently, cardiac function and mechanics. Increased cardiac inorganic phosphate levels and decreased myocardial ATP levels are the outcomes of this decrease in purine nucleotide levels. Both modifications can immediately affect cellular mechanical work and tension developmen…

  148. 171.

    Zhu W, Bo W, Ma Y. · 2025 · PMID 41488924

    Myocardial infarction (MI) often induces acute kidney injury (AKI) via systemic hypoperfusion and oxidative stress, yet the protective mechanisms of exercise remain unclear. This study investigated whether intermittent exercise alleviates MI-induced AKI through the insulin-like growth factor-1 (IGF-1)/PI3K/AKT signaling pathway. An AKI model was established in mice via coronary artery ligation, followed by moderate-intensity intermittent treadmill training for 4 weeks. Echocardiography, serum bi…

  149. 172.

    Brcic A, Lalic H, Smoljo T, Bardač K, Dembitz V, Penker R, Rodriguez Blanco G, Bedalov A, Visnjic D. · 2026 · PMID 42031709

    Differentiation therapy offers a promising approach in acute myeloid leukemia (AML) by overcoming the developmental block that maintains leukemic blasts. Increasing evidence indicates that DNA replication stress can promote differentiation rather than cytotoxicity; however, the metabolic mechanisms linking replication stress to differentiation remain poorly defined. Here, we investigated how perturbations in nucleotide metabolism regulate replication stress-driven differentiation. Using metabolo…

  150. 173.

    Smoljo T, Lalic H, Dembitz V, Tomic B, Batinic J, Vrhovac R, Bedalov A, Visnjic D. · 2024 · PMID 39279497

    Acute myeloid leukemia (AML) is a heterogeneous group of hematological malignancies characterized by differentiation arrest, high relapse rates, and poor survival. The bone marrow (BM) microenvironment is recognized as a critical mediator of drug resistance and a primary site responsible for AML relapse. Our previous study reported that 5-aminoimidazole-4-carboxamide ribonucleoside (AICAr) induces AML cell differentiation by inhibiting pyrimidine synthesis and activating Checkpoint kinase 1. Alt…

  151. 174.

    Husain F, Patrick CC, Roztocil E, Feldon SE, Woeller CF. · 2026 · PMID 41871797

    Thyroid eye disease (TED) is characterized by fibroblast-driven inflammation and extracellular matrix expansion, which contribute to orbital congestion and proptosis. Platelet-derived growth factor-β (PDGFβ) promotes hyaluronan (HA) synthesis and cytokine production in orbital fibroblasts (OFs); however, whether metabolic modulation can counteract this pathway is unknown. We tested whether metformin, an indirect activator of AMP-activated protein kinase (AMPK), attenuates PDGFβ signaling in TED…

  152. 175.

    Krishnan U A, Venkataraman AC, Ramachandran V. · 2025 · PMID 41272939

    Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease arising from the accumulation of lipids in the liver. Autophagy is an organized form of intracellular degradation process that eliminates damaged organelles and proteins. Reticulophagy (ER-phagy) is a selective type of autophagy in which a portion of the endoplasmic reticulum (ER) is sequestered and degraded within an autophagosome. ER-phagy is triggered by excessive ER-associated degradation levels resulting from an increased…

  153. 176.

    Maroto-Serrat C, Sanus F, Caballeria A, Liang S, Gracia-Sancho J, Casillas-Ramírez A, Peralta C. · 2026 · PMID 41856440

    Donor shortage has increased liver transplantation (LT) waiting lists. The use of livers grafts from extended criteria donors (ECD), including deceased donors with alcoholic liver disease (ALD) or severe steatosis, particularly after prolonged cold ischemia (CI), is associated with a risk of graft dysfunction and reduced post-liver transplantation outcomes. This study investigated whether hepatic NPY depletion in donors after brain death (DBD) and donors after cardiocirculatory death (DCD) contr…

  154. 177.

    Dennis MR, Zozobrado L, Reinartz DM, Foster T, Gauthier MM, Wilson JE, Banek CT. · 2025 · PMID 40947048

    Previous studies suggest that exercise training mitigates blood pressure in hypertensive animal models. While exercise training may be an effective therapeutic for hypertension treatment and prevention, many patients diagnosed with hypertension can be noncompliant with lifestyle modifications that involve physical activity or are unable to participate in strenuous activity due to the severity of their hypertension. AMP-activated protein kinase (AMPK) is responsive during metabolic stressors, pla…

  155. 178.

    Yu X, An D, Ren D, He P, Yang Y, Chen N, Wang R, Wu S, Feng J, Feng M. · 2026 · PMID 42042063

    Glucose deprivation is a major metabolic stress that requires coordinated adaptive responses to maintain cellular homeostasis and survival, yet the role of tripartite motif-containing 24 (TRIM24) in this process remains unclear. To address this question, we generated CRISPR-Cas9-mediated TRIM24-knockout MCF-7 and HEK293 cell lines, performed targeted metabolomic profiling and aspartate assays, used 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside (AICAR), aminooxyacetic acid (AOA), aspartate…

  156. 179.

    Su H, Liu C, Cheng Y, Cheng W, et al. · Materials today. Bio · 2026 · PMID 42899161

    Chronic diabetic wound healing is severely hampered by endothelial cell (EC) dysfunction, defective angiogenesis, and a persistent inflammatory microenvironment, yet the crosstalk between EC energy metabolism and macrophage polarization in this process remains poorly understood. Here, we identified an AMPK-dependent metabolic pathway in ECs that orchestrated both angiogenic restoration and macrophage immune reprogramming for diabetic wound repair, and translated this mechanism into a functional…

  157. 180.

    Liu S, Li L, Li J, Li S, et al. · Neurochemistry international · 2026 · PMID 42767463

    Hyperbilirubinemia arises from disrupted bilirubin homeostasis, which can lead to bilirubin encephalopathy (BE). Unconjugated bilirubin (UCB)-induced neuroinflammation plays a pivotal role in the pathogenesis and progression of BE. To delineate the role and molecular mechanisms of lipophagy in UCB-evoked neuroinflammation. Western blot, qPCR, immunofluorescence, ELISA, transmission electron microscopy, mCherry-EGFP-LC3 tandem fluorescent reporter, BODIPY staining, Nissl staining, and behavioral…

  158. 181.

    Lee ST, Kim HE, Kim SY, Lee JY, et al. · The Journal of allergy and clinical immunology · 2026 · PMID 42413788

    Atopic dermatitis (AD) is characterized by dysregulated immune responses and persistent inflammation. Regulatory B (Breg) cells suppress inflammation, but the metabolic mechanisms constraining their function in AD remain unclear. We sought to define whether immunometabolic regulation governs Breg cell differentiation and function in AD. Mouse and human B cells were stimulated with the adenosine monophosphate-activated protein kinase (AMPK) activator 5-aminoimidazole-4-carboxamide ribonucleotide…

  159. 182.

    Yue B, Xu F, Jiao X, Wang B, et al. · Cellular signalling · 2026 · PMID 42966434

    Diabetic cardiomyopathy (DCM) is a major cardiovascular complication of type 2 diabetes mellitus (T2D) characterized by metabolic dysregulation, oxidative stress, chronic inflammation, and progressive cardiac dysfunction. Although swimming exercise has been recognized as an effective non-pharmacological intervention for DCM, the molecular mechanisms underlying its cardioprotective effects remain poorly understood. This study aimed to identify the key exercise-responsive molecular targets involve…

  160. 183.

    Zou M, Zhang T, He L, Li J, et al. · Frontiers in oncology · 2026 · PMID 42990857

    5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR), an AMP-activated protein kinase (AMPK) agonist, exhibits potent antitumor capacity across various malignancies. However, its efficacy and underlying mechanisms in esophageal squamous cell carcinoma (ESCC) remain largely unexplored. We treated HEEC, TE1, and TE13 cells with AICAR and assessed proliferation, cell cycle distribution, and expression of key signaling proteins, followed by SN38 cotreatment to evaluate apoptosis and chemosens…

  161. 184.

    Colón-Vázquez J, Hernández-Santiago Y, Malpica-Nieves CJ, Rosado-Rivera NM, et al. · Cells · 2026 · PMID 42929878

    The effects of chronic hyperglycemia on CNS, glial homeostasis and Kir4.1 regulation is poorly understood. Elevated blood glucose levels affect polyamine-sensitive inwardly rectifying potassium channels, Kir4.1, in astrocytes and retinal Müller glial cells. These cells regulate extracellular potassium and clear glutamate, processes supported by Kir4.1. Dysregulation of Kir4.1 channels has been implicated in glutamate toxicity, epilepsy, ataxia, and diabetes-induced neurodegeneration. In this stu…

  162. 185.

    Qiu H, Chen J, Li L, Liu J, et al. · Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2026 · PMID 42896827

    Allergic rhinitis (AR) is a chronic IgE-mediated inflammatory disease characterized by nasal epithelial barrier dysfunction. Interleukin-17A (IL-17A) has been implicated in epithelial barrier disruption, but its role in regulating nasal epithelial tight junctions (TJs) remains unclear. To investigate the effects of IL-17A on nasal epithelial TJs integrity and determine whether adenosine monophosphate-activated protein kinase (AMPK) signaling mediates IL-17A-induced barrier dysfunction in AR. Inf…

  163. 186.

    Pan H, Zhai L, Zhao S, Guo Z, et al. · PloS one · 2026 · PMID 42842576

    A high-fat diet (HFD) is closely associated with the progression of ulcerative colitis (UC). However, the underlying mechanisms, particularly the interplay among lipid metabolic disturbances, mitochondrial damage, and intestinal barrier dysfunction, remain poorly defined. This study aimed to elucidate the molecular mechanisms by which HFD exacerbates DSS-induced UC, with a focus on the role of the AMPK/PPARα axis in mediating lipotoxicity and mitochondrial dysfunction that promote UC progression…

  164. 187.

    Li JX, Ji B, Xie JJ, Guo XQ, et al. · Chinese journal of integrative medicine · 2026 · PMID 42720843

    To elucidate the therapeutic mechanism of holistic regulation of body and mind (HRBM) acupuncture in chronic fatigue syndrome (CFS) by focusing on leptin receptor (LepR)-AMP-activated protein kinase (AMPK) signaling to address mitochondrial dysfunction and oxidative stress. A CFS rat model was established by a 4-week treadmill-based exhaustive exercise protocol. After modeling, 50 rats were randomly allocated into 5 groups (n=10), control, CFS (model), acupuncture (Acu), Acu + Allo-aca, and Acu…

  165. 188.

    Torsti T, Hytti M, Toppila M, Forsberg MM, et al. · Biochemical and biophysical research communications · 2026 · PMID 42308764

    Juvenile neuronal lipofuscinosis (JNCL) is a rare disease caused by mutations in the CLN3 gene. It leads to early vision loss mediated by retinal degeneration. Impaired autophagosomal-lysosomal degradation is a major hallmark of JNCL pathology, and neuroinflammation has also been postulated to play a role in its pathogenesis. Thapsigargin, a selective inhibitor of sarco/endoplasmic reticulum Ca

  166. 189.

    Yan X, Chen G, Huang Y, Yang S, et al. · Chemico-biological interactions · 2026 · PMID 42392248

    Hypoxia disrupts corneal physiological function by impairing energy metabolism. We identify AMP-activated protein kinase (AMPK) as a central regulator of coordinated metabolic adaptation in the hypoxic cornea. Using human corneal epithelial cells and an alkali burn-induced mouse model of corneal hypoxia, we combined metabolic flux analysis, mitochondrial morphology assessment and pathway-specific pharmacological and molecular approaches to characterize AMPK-dependent metabolic regulation. We dem…

  167. 190.

    Liu Q, Chang X, Jing W, Liu S · Translational pediatrics · 2026 · PMID 42724239

    Mucus hypersecretion and obesity are two prevalent comorbidities that independently worsen childhood asthma outcomes. However, the metabolic mechanisms by which obesity-related factors interact with type 2 (T2) inflammatory signals to exacerbate airway epithelial mucus phenotype remain poorly understood. This study aimed to investigate whether palmitic acid (PA), a representative obesity-related saturated fatty acid, amplifies interleukin-13 (IL-13)-induced mucus phenotype in human bronchial epi…

  168. 191.

    Xu Y, Tang J, Wu C, Li R, et al. · Journal of cardiovascular translational research · 2026 · PMID 42565937

    Ferroptosis critically mediates myocardial ischemia/reperfusion (I/R) injury. Exercise training confers cardioprotection, but whether it protects against I/R-induced ferroptosis and the underlying mechanisms remain unclear. In this study, C57BL/6J mice underwent six weeks of treadmill exercise preconditioning (EP) before myocardial I/R induction. Cardiac function, oxidative stress, ferroptosis markers and the phosphorylation of AMPK and ACC were assessed. In vitro, H9C2 cells were subjected to h…

  169. 192.

    Niu DD, Wang C, Duan CE · Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica · 2026 · PMID 42543344

    This study focused on the protective effect of costunolide(COS) against sorafenib(SOR)-induced cardiomyocyte injury and its association with mitophagy. Cell viability was assessed using the CCK-8 assay. H9c2 cells were divided into six groups: control(ctrl) group, SOR group, SOR + low-dose COS(SOR+low-COS) group, SOR + high-dose COS(SOR+high-COS) group, SOR + high-COS + rapamycin group, and SOR + high-COS + adenosine monophosphate-activated protein kinase(AMPK) activator(AICAR) group, with each…

  170. 193.

    Yan X, Guan Y, Chen G, Yang S, et al. · Cell biology and toxicology · 2026 · PMID 42387096

    Hypoxia disrupts corneal stromal physiology and alters cellular energy metabolism. This study aimed to elucidate the molecular role of the cellular energy sensor AMP-activated protein kinase (AMPK) in modulating the energy metabolism of human keratocytes (HKs) under hypoxic conditions and to explore a potential therapeutic strategy. In vitro, HKs were exposed to 1% O₂ for 2 h and 24 h to simulate hypoxia. In vivo, a mouse corneal alkali burn model was established, in which hypoxia is recognized…

  171. 194.

    Xiang H, Li M, Jing X, Hu L, et al. · Molecular pain · 2026 · PMID 42808530

    Electroacupuncture (EA) effectively alleviates inflammatory pain, yet its underlying mechanisms remain incompletely understood. Emerging evidence implicates AMP-activated protein kinase (AMPK) and autophagy in modulating inflammation, but whether they mediate EA's analgesic action is unknown. This study tests the hypothesis that EA relieves inflammatory pain by activating AMPK in macrophages, thereby triggering autophagy and suppressing pro-inflammatory mediators (iNOS and IL-1β) in inflamed tis…

Preprints (not yet peer-reviewed)

4
  1. 195.

    Xiang L, Calderon AS, Kennard CA, Ryan KL, Klemcke HG, Grantham LE, Mdaki KS, Lipiec SM, Meledeo MA. · 2025

    <h4>Background: </h4> While anti-shock therapy provided early after hemorrhage may be beneficial, the problem of delivery of potential therapeutics to ischemic tissue has not been well-appreciated. Polydatin (PD) and 5-aminoimidazole-4-carboxamide 1-β-D-ribonucleoside (AICAR) alleviate mitochondrial dysfunction and acute renal injury (AKI) following resuscitation, but it is unclear whether PD or AICAR are still effective before resuscitation when drug delivery can be still impeded. Because a low…

  2. 196.

    Gan L, Li W, Zhang Y, Zeng J, Xu B. · 2025

    <title>Abstract</title> <p>This study aims to elucidate the synergistic protective mechanism of the AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) in renal ischemia-reperfusion injury-associated acute kidney injury (IRI-AKI). By establishing a hypoxia/reoxygenation (H/R) injury model using human proximal tubule cells (HK-2) and IRI-AKI rat model, and employing molecular techniques including qRT-PCR, western blotting, serum biochemical assays, renal tissue hematoxylin and eosi…

  3. 197.

    Fassett EK, Mayer B, Fassett JT. · 2025

    Doxorubicin is an effective cancer chemotherapeutic, but its use is complicated by cardiotoxic side-effects. 5-amino-4-imidazolecarboxamide ribonucleoside (AICAr) is a widely used pharmacological activator of adenosine monophosphate activated kinase (AMPK), but also exerts AMPK-independent actions that may have unrealized therapeutic potential. Here, we identified a novel mechanism by which pretreatment with AICAr protects neonatal rat cardiomyocytes against doxorubicin toxicity. Despite increas…

  4. 198.

    Chandrasekaran K, Choi J, Salimian M, Hedayat AF, Hsia R, Russell JW. · 2026

    Diabetes increases the risk of cognitive impairment and Alzheimer’s disease, but the mechanisms linking metabolic stress to hippocampal neurodegeneration remain unclear. We investigated whether disruption of PINK1-AMPK signaling contributes to Diabetes Induced Cognitive Impairment (DCI) and whether activation of AMPK with 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) prevents critical metabolic, cognitive, and neuropathology processes. Hippocampal tissue from diabetic and non-diabetic hu…

Curated sources on file

6
  1. 1.
  2. 2.
  3. 3.
  4. 4.
  5. 5.
  6. 6.

Continue reading